<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">evrazkar</journal-id><journal-title-group><journal-title xml:lang="ru">Евразийский Кардиологический Журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Eurasian heart journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2225-1685</issn><issn pub-type="epub">2305-0748</issn><publisher><publisher-name>Евразийская ассоциация кардиологов</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.38109/2225-1685-2026-3-6-71</article-id><article-id custom-type="elpub" pub-id-type="custom">evrazkar-6614</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КОНСЕНСУС</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CONSENSUS</subject></subj-group></article-categories><title-group><article-title>Клиническое применение магнитно-резонансной томографии сердца в кардиологии. Консенсус Евразийской Ассоциации Кардиологов (ЕАК) (2026)</article-title><trans-title-group xml:lang="en"><trans-title>Clinical Applications of Cardiac Magnetic Resonance Imaging in Cardiology. Consensus Statement of the Eurasian Association of Cardiologists (EAC) (2026)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8377-2388</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Стукалова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Stukalova</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Стукалова Ольга Владимировна, д.м.н., доцент, ведущий научный сотрудник, отдел томографии</p><p>ул. Академика Чазова, дом 15 а, г. Москва 121552 </p></bio><bio xml:lang="en"><p>Olga V. Stukalova, Dr. of Sci. (Med.), Associate Professor, Leading Researcher, Department of Tomography </p><p>Moscow</p></bio><email xlink:type="simple">olgastukalova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7795-9709</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Александрова</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Aleksandrova</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Александрова Светлана Александровна, к.м.н., врач-рентгенолог, заведующая рентгеновским отделением №2, Центр лучевой диагностики; доцент кафедры кардиологии, функциональной и ультразвуковой диагностики с курсом детской кардиологии, Институт подготовки кадров высшей квалификации и профессионального образования</p><p>г. Москва </p></bio><bio xml:lang="en"><p>Svetlana A. Aleksandrova, Cand. of Sci. (Med.),Head and Radiologist, X-ray Department No. 2, Center for Diagnostic Imaging; Associate Professor, Department of Cardiology, Functional and Ultrasound Diagnostics with a Course in Pediatric Cardiology, Institute of Higher Qualification Training and Professional Education</p><p>Moscow </p></bio><email xlink:type="simple">valeksandrova@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5267-0108</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Даутов</surname><given-names>Т. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Dautov</surname><given-names>T. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Даутов Таирхан Бекполатович, д.м.н., профессор, главный внештатный специалист по лучевой диагностике и интервенционной радиологии, директор Департамента радиологии и ядерной медицины</p><p>г. Астана </p></bio><bio xml:lang="en"><p>Tairkhan B. Dautov, Dr. of Sci. (Med.), Professor, Chief External Specialist in Radiology and Interventional Radiology; Director of the Clinical-Academic Department of Radiology and Nuclear Medicine</p><p>Astana</p></bio><email xlink:type="simple">tairkhan.dautov@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6845-5613</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зяблова</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Zyablova</surname><given-names>E. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зяблова Елена Игоревна, д.м.н., доцент, заведующая рентгеновским отделением; заведующая кафедрой лучевой диагностики 2; главный внештатный специалист по лучевой и инструментальной диагностике Минздрава Краснодарского края</p><p>г. Краснодар </p></bio><bio xml:lang="en"><p>Elena I. Zyablova, Dr. of Sci. (Med.), Associate Professor, Head of the Department of Radiology; Head of the Department of Radiology No. 2, Kuban State Medical University; Chief External Specialist in Radiology and Instrumental Diagnostics</p><p>Krasnodar</p></bio><email xlink:type="simple">elenazyablova@inbox.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-6840-2719</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мусаева</surname><given-names>Л. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Musayeva</surname><given-names>L. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мусаева Лейла Бахтияровна, к.м.н., врач-рентгенолог </p><p>г. Баку </p></bio><bio xml:lang="en"><p>Leyla B. Musayeva, Cand. of Sci. (Med.) </p><p>Baku</p></bio><email xlink:type="simple">leyla.musayeva@gmail.com</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3952-6865</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Першина</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Pershina</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Першина Екатерина Сергеевна, к.м.н., заместитель главного врача по перспективному развитию, руководитель Центра лучевой диагностики; доцент кафедры кардиологии, ультразвуковой и функциональной диагностики</p><p>г. Москва </p></bio><bio xml:lang="en"><p>Ekaterina S. Pershina, Cand. of Sci. (Med.), Deputy Chief Physician for Strategic Development, Head of the Center for Diagnostic Imaging; Associate Professor, Department of Cardiology, Ultrasound and Functional Diagnostics</p><p>Moscow</p></bio><email xlink:type="simple">pershina86@mail.ru</email><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3585-9793</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рудь</surname><given-names>С. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Rud</surname><given-names>S. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рудь Сергей Дмитриевич, к.м.н., доцент, преподаватель кафедры рентгенологии и радиологии с курсом ультразвуковой диагностики; заведующий рентгеновским отделением, Сеть медицинских центров ООО «АЙ-КЛИНИК ПЕТЕРГОФ»</p><p>г. Санкт-Петербург </p></bio><bio xml:lang="en"><p>Sergey D. Rud, Cand. of Sci. (Med.), Head of the Department of Radiology, Lecturer Department of Radiology and Ultrasound with a Course Ultrasound Diagnostic</p><p>Saint Petersburg</p></bio><email xlink:type="simple">rsd@mail.ru</email><xref ref-type="aff" rid="aff-7"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6905-8890</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сухова</surname><given-names>М. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Sukhova</surname><given-names>M. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сухова Марина Борисовна, д.м.н., доцент, заведующая рентгенодиагностическим отделением; заведующая кафедрой лучевой диагностики, ФГБОУ ВО «ПИМУ» Минздрава России </p><p>г. Нижний Новгород </p></bio><bio xml:lang="en"><p>Marina B. Sukhova, Dr. of Sci. (Med.), Associate Professor, Head of the Department of Diagnostic Radiology; Head of the Department of Radiology, Privolzhsky Research Medical University</p><p>Nizhny Novgorod</p></bio><email xlink:type="simple">skkbnn@gmail.com</email><xref ref-type="aff" rid="aff-8"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7885-9024</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фокин</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Fokin</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фокин Владимир Александрович, д.м.н., профессор, профессор кафедры лучевой диагностики и медицинской визуализации с клиникой лечебного факультета, Институт медицинского образования</p><p>г. Санкт-Петербург </p></bio><bio xml:lang="en"><p>Vladimir A. Fokin, Dr. of Sci. (Med.), Professor, Professor of the Department of Radiology and Medical Imaging with a Clinic of the Faculty of Medicine, Institute of Medical Education</p><p>Saint Petersburg</p></bio><email xlink:type="simple">vladfokin@mail.ru</email><xref ref-type="aff" rid="aff-9"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4374-1063</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Терновой</surname><given-names>С. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Ternovoy</surname><given-names>S. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Терновой Сергей Константинович, академик РАН, д.м.н., профессор, главный научный сотрудник, отдел томографии; заведующий кафедрой лучевой диагностики и лучевой терапии</p><p>г. Москва </p></bio><bio xml:lang="en"><p>Sergey K. Ternovoy, Academician of the Russian Academy of Sciences, Dr. of Sci. (Med.), Professor, Chief Researcher, Department of Tomography; Head of the Department of Radiology and Radiation Therapy</p><p>Moscow</p></bio><email xlink:type="simple">prof_ternovoy@list.ru</email><xref ref-type="aff" rid="aff-10"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ кардиологии им. академика Е.И. Чазова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>E.I. Chazov National Medical Research Center of Cardiology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ ССХ им. А.Н. Бакулева» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>A.N. Bakulev National Medical Research Center for Cardiovascular Surgery</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Центр сердца корпоративного фонда «UMC», клинико-академический департамент радиологии и ядерной медицины</institution><country>Казахстан</country></aff><aff xml:lang="en"><institution>“UMC” Corporate Foundation</institution><country>Kazakhstan</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ГБУЗ «Научно-исследовательский институт – Краевая клиническая больница №1 им. Профессора С.В. Очаповского» Минздрава Краснодарского края</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute - S. V. Ochapovsky Regional Clinical Hospital No. 1</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>Yeni Klinika/ Центральная клиническая больница</institution><country>Азербайджан</country></aff><aff xml:lang="en"><institution>Yeni Klinika/ Central Clinical Hospital</institution><country>Azerbaijan</country></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Сеченовский Университет) ; Центр лучевой диагностики ГКБ №1 им. Н.И. Пирогова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University (Sechenov University) ; N.I. Pirogov City Clinical Hospital No. 1</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-7"><aff xml:lang="ru"><institution>ФГБВОУВО «Военно -медицинская академия им. С.М. Кирова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>S.M. Kirov Medical Military Academy</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-8"><aff xml:lang="ru"><institution>ГБУЗ НО «НИИ-СККБ им. акад. Б.А. Королева»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>B.A. Korolev Research Institute - Specialized Clinical Cardiology Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-9"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр им. В.А. Алмазова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Almazov National Medical Research Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-10"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр кардиологии им. академика Е.И. Чазова» Минздрава России ; ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>E.I. Chazov National Medical Research Center of Cardiology ; I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>30</day><month>09</month><year>2026</year></pub-date><volume>0</volume><issue>3</issue><fpage>6</fpage><lpage>71</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Стукалова О.В., Александрова С.А., Даутов Т.Б., Зяблова Е.И., Мусаева Л.Б., Першина Е.С., Рудь С.Д., Сухова М.Б., Фокин В.А., Терновой С.К., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Стукалова О.В., Александрова С.А., Даутов Т.Б., Зяблова Е.И., Мусаева Л.Б., Першина Е.С., Рудь С.Д., Сухова М.Б., Фокин В.А., Терновой С.К.</copyright-holder><copyright-holder xml:lang="en">Stukalova O.V., Aleksandrova S.A., Dautov T.B., Zyablova E.I., Musayeva L.B., Pershina E.S., Rud S.D., Sukhova M.B., Fokin V.A., Ternovoy S.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.heartj.asia/jour/article/view/6614">https://www.heartj.asia/jour/article/view/6614</self-uri><abstract><p>Консенсус посвящен современным возможностям магнитно-резонансной томографии сердца в клинической практике кардиолога. В документе обобщены данные клинических рекомендаций и практический опыт применения МРТ при наиболее распространенных сердечно-сосудистых заболеваниях. Особое внимание уделено показаниям к исследованию, оптимальным протоколам сканирования, интерпретации результатов и влиянию полученной информации на выбор лечебной тактики и прогноз пациентов. Рассмотрены возможности МРТ в диагностике ишемической болезни сердца, кардиомиопатий, миокардитов, воспалительных заболеваний сердца, опухолей, кардиоонкологических осложнений, врожденных пороков сердца. Представлены современные подходы к тканевой характеристике миокарда, включая методы параметрического картирования и отсроченного контрастирования, позволяющие проводить неинвазивную оценку воспаления, фиброза, инфильтрации и жизнеспособности миокарда. Особое место отведено практическим аспектам использования МРТ в сложных клинических ситуациях, когда результаты исследования оказывают непосредственное влияние на постановку диагноза и принятие клинических решений. Документ ориентирован прежде всего на практикующих кардиологов, однако может быть полезен специалистам по лучевой диагностике, кардиохирургам, врачам функциональной диагностики и другим специалистам, участвующим в обследовании пациентов с сердечнососудистыми заболеваниями. Авторы надеются, что представленные рекомендации будут способствовать более широкому и рациональному применению МРТ сердца, повышению качества диагностики и улучшению результатов лечения пациентов.</p></abstract><trans-abstract xml:lang="en"><p>This consensus document summarizes the current role of cardiovascular magnetic resonance (CMR) in contemporary cardiology practice. It integrates the latest evidence, international guideline recommendations, and practical experience regarding the use of CMR in the diagnosis and management of the most common cardiovascular diseases. Particular attention is given to the appropriate clinical indications for CMR, standardized imaging protocols, interpretation of imaging findings, and their impact on clinical decision-making and patient outcomes. The document reviews the application of CMR in ischemic heart disease, cardiomyopathies, myocarditis, inflammatory heart diseases, cardiac tumors, cardio-oncology, and congenital heart disease. Modern techniques for myocardial tissue characterization, including late gadolinium enhancement and parametric mapping, are discussed as essential tools for the non-invasive assessment of myocardial fibrosis, inflammation, infiltration, and viability. Special emphasis is placed on the practical use of CMR in complex clinical scenarios where imaging findings directly influence diagnosis, risk stratification, and therapeutic strategy. This consensus is primarily intended for practicing cardiologists but will also be of value to radiologists, cardiac surgeons, cardiovascular imaging specialists, and other healthcare professionals involved in the care of patients with cardiovascular disease. The authors hope that this document will promote the appropriate and wider implementation of CMR in routine clinical practice, ultimately improving diagnostic accuracy, patient management, and clinical outcomes.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>магнитно-резонансная томография сердца</kwd><kwd>неинвазивная диагностика</kwd><kwd>диагностика сердечно-сосудистых заболеваний</kwd><kwd>тканевая характеристика миокарда</kwd><kwd>мультимодальная визуализация</kwd><kwd>диагностический алгоритм</kwd></kwd-group><kwd-group xml:lang="en"><kwd>сardiac magnetic resonance imaging</kwd><kwd>non-invasive diagnosis</kwd><kwd>сardiovascular disease diagnosis</kwd><kwd>myocardial tissue characterization</kwd><kwd>multimodality imaging</kwd><kwd>diagnostic algorithm</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Pohost G.M. The history of cardiovascular magnetic resonance. JACC Cardiovasc Imaging. 2008;1:672–678. https://doi.org/10.1016/j.jcmg.2008.07.009</mixed-citation><mixed-citation xml:lang="en">Pohost G.M. The history of cardiovascular magnetic resonance. JACC Cardiovasc Imaging. 2008;1:672–678. https://doi.org/10.1016/j.jcmg.2008.07.009</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Herfkens R.J., Higgins C.B., Hricak H., et al. Nuclear magnetic resonance imaging of the cardiovascular system: normal and pathologic findings. Radiology. (1983) 147(3):749–59. https://doi.org/10.1148/radiology.147.3.6601813</mixed-citation><mixed-citation xml:lang="en">Herfkens R.J., Higgins C.B., Hricak H., et al. Nuclear magnetic resonance imaging of the cardiovascular system: normal and pathologic findings. Radiology. (1983) 147(3):749–59. https://doi.org/10.1148/radiology.147.3.6601813</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Беленков Ю.Н., Терновой С.К., Синицын В.Е. Магнитно-резонансная томография сердца и сосудов. - М.: Видар, 1997.- 144 с.</mixed-citation><mixed-citation xml:lang="en">Belenkov Yu.N., Ternovoy S.K., Sinitsyn V.E. Magnetic Resonance Imaging of the Heart and Blood Vessels. – Moscow: Vidar, 1997. – 144 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Longmore D.B., Klipstein R.H., Underwood S.R., et al. Dimensional accuracy of magnetic resonance in studies of the heart. Lancet. 1985;1(8442):1360–1362. https://doi.org/10.1016/s0140-6736(85)91786-6</mixed-citation><mixed-citation xml:lang="en">Longmore D.B., Klipstein R.H., Underwood S.R., et al. Dimensional accuracy of magnetic resonance in studies of the heart. Lancet. 1985;1(8442):1360–1362. https://doi.org/10.1016/s0140-6736(85)91786-6</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Curtis AD, Cheng HM. Primer and Historical Review on Rapid Cardiac CINE MRI. J Magn Reson Imaging. 2022 Feb;55(2):373- 388. https://doi.org/10.1002/jmri.27436</mixed-citation><mixed-citation xml:lang="en">Curtis AD, Cheng HM. Primer and Historical Review on Rapid Cardiac CINE MRI. J Magn Reson Imaging. 2022 Feb;55(2):373- 388. https://doi.org/10.1002/jmri.27436</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mohiaddin RH, Longmore DB. Functional aspects of cardiovascular nuclear magnetic resonance imaging. Techniques and application. Circulation. 1993;88:264–281. https://doi.org/10.1161/01.cir.88.1.264</mixed-citation><mixed-citation xml:lang="en">Mohiaddin RH, Longmore DB. Functional aspects of cardiovascular nuclear magnetic resonance imaging. Techniques and application. Circulation. 1993;88:264–281. https://doi.org/10.1161/01.cir.88.1.264</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–1453. https://doi.org/10.1056/NEJM200011163432003</mixed-citation><mixed-citation xml:lang="en">Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–1453. https://doi.org/10.1056/NEJM200011163432003</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology. J Cardiovasc Magn Reson. 2016;18:6. Published 2016 Jan 22. https://doi.org/10.1186/s12968-016-0225-6</mixed-citation><mixed-citation xml:lang="en">von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology. J Cardiovasc Magn Reson. 2016;18:6. Published 2016 Jan 22. https://doi.org/10.1186/s12968-016-0225-6</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Pedrosa I, Altman DA, Dillman JR, et al. American College of Radiology Manual on MR Safety: 2024 Update and Revisions. Radiology. 2025;315(1):e241405. https://doi.org/10.1148/radiol.241405</mixed-citation><mixed-citation xml:lang="en">Pedrosa I, Altman DA, Dillman JR, et al. American College of Radiology Manual on MR Safety: 2024 Update and Revisions. Radiology. 2025;315(1):e241405. https://doi.org/10.1148/radiol.241405</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kim D, Collins JD, White JA, et al. SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device. J Cardiovasc Magn Reson. 2024;26(1):100995. https://doi.org/10.1016/j.jocmr.2024.100995</mixed-citation><mixed-citation xml:lang="en">Kim D, Collins JD, White JA, et al. SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device. J Cardiovasc Magn Reson. 2024;26(1):100995. https://doi.org/10.1016/j.jocmr.2024.100995</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Nazarian S, Hansford R, Rahsepar AA, et al. Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices. N Engl J Med. 2017;377(26):2555-2564. https://doi.org/10.1056/NEJMoa1604267</mixed-citation><mixed-citation xml:lang="en">Nazarian S, Hansford R, Rahsepar AA, et al. Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices. N Engl J Med. 2017;377(26):2555-2564. https://doi.org/10.1056/NEJMoa1604267</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">ASTM International. Standard Practice for Marking Medical Devices and Other Items for Safety in the Magnetic Resonance Environment. ASTM F2503-20.</mixed-citation><mixed-citation xml:lang="en">ASTM International. Standard Practice for Marking Medical Devices and Other Items for Safety in the Magnetic Resonance Environment. ASTM F2503-20.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Levine GN, Gomes AS, Arai AE, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation. 2007;116(24):2878-2891. https://doi.org/10.1161/CIRCULATIONAHA.107.187256</mixed-citation><mixed-citation xml:lang="en">Levine GN, Gomes AS, Arai AE, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation. 2007;116(24):2878-2891. https://doi.org/10.1161/CIRCULATIONAHA.107.187256</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Shellock FG. Reference Manual for Magnetic Resonance Safety, Implants, and Devices. 2020 Edition</mixed-citation><mixed-citation xml:lang="en">Shellock FG. Reference Manual for Magnetic Resonance Safety, Implants, and Devices. 2020 Edition</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Bhuva A, Charles-Edwards G, Ashmore J, et al. Joint British Society consensus recommendations for magnetic resonance imaging for patients with cardiac implantable electronic devices. Heart. 2024;110(4):e3. Published 2024 Jan 29. https://doi.org/10.1136/heartjnl-2022-320810</mixed-citation><mixed-citation xml:lang="en">Bhuva A, Charles-Edwards G, Ashmore J, et al. Joint British Society consensus recommendations for magnetic resonance imaging for patients with cardiac implantable electronic devices. Heart. 2024;110(4):e3. Published 2024 Jan 29. https://doi.org/10.1136/heartjnl-2022-320810</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Dewey M, Schink T, Dewey CF. Claustrophobia during magnetic resonance imaging: cohort study in over 55,000 patients. J Magn Reson Imaging. 2007;26(5):1322-1327. https://doi.org/10.1002/jmri.21147</mixed-citation><mixed-citation xml:lang="en">Dewey M, Schink T, Dewey CF. Claustrophobia during magnetic resonance imaging: cohort study in over 55,000 patients. J Magn Reson Imaging. 2007;26(5):1322-1327. https://doi.org/10.1002/jmri.21147</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Enders J, Zimmermann E, Rief M, et al. Reduction of claustrophobia during magnetic resonance imaging: methods and design of the "CLAUSTRO" randomized controlled trial. BMC Med Imaging. 2011;11:4. Published 2011 Feb 10. https://doi.org/10.1186/1471-2342-11-4</mixed-citation><mixed-citation xml:lang="en">Enders J, Zimmermann E, Rief M, et al. Reduction of claustrophobia during magnetic resonance imaging: methods and design of the "CLAUSTRO" randomized controlled trial. BMC Med Imaging. 2011;11:4. Published 2011 Feb 10. https://doi.org/10.1186/1471-2342-11-4</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kramer CM, Barkhausen J, Bucciarelli-Ducci C, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson. 2020;22(1):17. Published 2020 Feb 24. https://doi.org/10.1186/s12968-020-00607-1</mixed-citation><mixed-citation xml:lang="en">Kramer CM, Barkhausen J, Bucciarelli-Ducci C, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson. 2020;22(1):17. Published 2020 Feb 24. https://doi.org/10.1186/s12968-020-00607-1</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">ACR Manual on MR Safety. 2024.</mixed-citation><mixed-citation xml:lang="en">ACR Manual on MR Safety. 2024.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ray JG, Vermeulen MJ, Bharatha A, Montanera WJ, Park AL. Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes. JAMA. 2016;316(9):952-961. https://doi.org/10.1001/jama.2016.12126</mixed-citation><mixed-citation xml:lang="en">Ray JG, Vermeulen MJ, Bharatha A, Montanera WJ, Park AL. Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes. JAMA. 2016;316(9):952-961. https://doi.org/10.1001/jama.2016.12126</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">European Society of Urogenital Radiology (ESUR) Guidelines on Contrast Agents, Version 10.0; ACR Manual on Contrast Media, 2024.</mixed-citation><mixed-citation xml:lang="en">European Society of Urogenital Radiology (ESUR) Guidelines on Contrast Agents, Version 10.0; ACR Manual on Contrast Media, 2024.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kim RJ, Albert TS, Wible JH, et al. Performance of delayedenhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation. 2008;117(5):629-637. https://doi.org/10.1161/CIRCULATIONAHA.107.723262</mixed-citation><mixed-citation xml:lang="en">Kim RJ, Albert TS, Wible JH, et al. Performance of delayedenhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation. 2008;117(5):629-637. https://doi.org/10.1161/CIRCULATIONAHA.107.723262</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">American College of Radiology. ACR Manual on Contrast Media. Version 2024.</mixed-citation><mixed-citation xml:lang="en">American College of Radiology. ACR Manual on Contrast Media. Version 2024.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Woolen SA, Shankar PR, Gagnier JJ, MacEachern MP, Singer L, Davenport MS. Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Metaanalysis. JAMA Intern Med. 2020;180(2):223-230. https://doi.org/10.1001/jamainternmed.2019.5284</mixed-citation><mixed-citation xml:lang="en">Woolen SA, Shankar PR, Gagnier JJ, MacEachern MP, Singer L, Davenport MS. Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Metaanalysis. JAMA Intern Med. 2020;180(2):223-230. https://doi.org/10.1001/jamainternmed.2019.5284</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Gulani V, Calamante F, Shellock FG, Kanal E, Reeder SB; International Society for Magnetic Resonance in Medicine. Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol. 2017;16(7):564-570. https://doi.org/10.1016/S1474-4422(17)30158-8</mixed-citation><mixed-citation xml:lang="en">Gulani V, Calamante F, Shellock FG, Kanal E, Reeder SB; International Society for Magnetic Resonance in Medicine. Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol. 2017;16(7):564-570. https://doi.org/10.1016/S1474-4422(17)30158-8</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Currie S, Hoggard N, Craven IJ, Hadjivassiliou M, Wilkinson ID. Understanding MRI: basic MR physics for physicians. Postgraduate Medical Journal. 2013;89:209-223. https://doi.org/10.1136/postgradmedj-2012-131342</mixed-citation><mixed-citation xml:lang="en">Currie S, Hoggard N, Craven IJ, Hadjivassiliou M, Wilkinson ID. Understanding MRI: basic MR physics for physicians. Postgraduate Medical Journal. 2013;89:209-223. https://doi.org/10.1136/postgradmedj-2012-131342</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Russo V, Lovato L, Ligabue G. Cardiac MRI: technical basis. Radiologia Medica. 2020;125:1040-1055. https://doi.org/10.1007/s11547-020-01282-z</mixed-citation><mixed-citation xml:lang="en">Russo V, Lovato L, Ligabue G. Cardiac MRI: technical basis. Radiologia Medica. 2020;125:1040-1055. https://doi.org/10.1007/s11547-020-01282-z</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Терновой С.К., Белькинд М.Б., Веселова Т.Н. и соавт. Магнитно-резонансная томография сердца. – Москва: ГЭОТАР-Медиа, 2018. – 296 с. – ISBN 978-5-9704-4608-9.</mixed-citation><mixed-citation xml:lang="en">Ternovoy S.K., Belkind M.B., Veselova T.N. et al. Magnetic resonance imaging of the heart. – Moscow: GEOTAR-Media, 2018. – 296 p. – ISBN 978-5-9704-4608-9. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Стукалова О.В., Беляевская А.А., Терновой С.К. Оценка фракции выброса левого желудочка с помощью кино-МРТ без задержки дыхания и синхронизации с ЭКГ. Российский электронный журнал лучевой диагностики. 2024;14(1):89-97. https://doi.org/10.21569/2222-7415-2024-14-1-89-97</mixed-citation><mixed-citation xml:lang="en">Stukalova O.V., Beliaevskaia A.A., Ternovoy S.K. Assessment of left ventricular ejection fraction using cine-MRI without breathholding and synchronization with ECG. Russian Electronic Journal of Radiology. 2024;14(1):89-97. (In Russ.) https://doi.org/10.21569/2222-7415-2024-14-1-89-97</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendationsfor cardiovascular magnetic resonance mapping of T1, T2, T2* and extracel-lular volume: A consensus statement by the Society for Cardiovascular Mag-netic Resonance (SCMR) endorsed by the European Association for Car-diovascular Imaging (EACVI). J Cardiovasc Magn Reson 2017;19(1):75. [Published correction appears in J Cardiovasc Magn Reson 2018;20(1):9. https://doi.org/10.1186/s12968-017-0408-9]</mixed-citation><mixed-citation xml:lang="en">Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendationsfor cardiovascular magnetic resonance mapping of T1, T2, T2* and extracel-lular volume: A consensus statement by the Society for Cardiovascular Mag-netic Resonance (SCMR) endorsed by the European Association for Car-diovascular Imaging (EACVI). J Cardiovasc Magn Reson 2017;19(1):75. [Published correction appears in J Cardiovasc Magn Reson 2018;20(1):9. https://doi.org/10.1186/s12968-017-0408-9]</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Ferreira VM, Piechnik SK. CMR parametric mapping as a tool for myocardial tissue characterization. Korean Circ J 2020;50(8):658– 676. https://doi.org/10.4070/kcj.2020.0157</mixed-citation><mixed-citation xml:lang="en">Ferreira VM, Piechnik SK. CMR parametric mapping as a tool for myocardial tissue characterization. Korean Circ J 2020;50(8):658– 676. https://doi.org/10.4070/kcj.2020.0157</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Соболева Г.Н., Пивоварова А.И., Стукалова О.В., и соавт. Возможности качественного и полуколичественного анализа перфузии миокарда по данным стресс-МРТ сердца с аденозинтрифосфатом в диагностике обструктивного атеросклероза коронарных артерий. Кардиоваскулярная терапия и профилактика. 2024;23(7);74-83. https://doi.org/10.15829/1728-8800-2024-4000</mixed-citation><mixed-citation xml:lang="en">Soboleva G.N., Pivovarova A.I., Stukalova O.V., Ternovoy S.K., Karpov Yu.A. Potential of qualitative and semi-quantitative analysis of myocardial perfusion according to stress adenosine triphosphate perfusion cardiac MRI in the diagnosis of obstructive coronary artery disease. Cardiovascular Therapy and Prevention. 2024;23(7):4000. (In Russ.) https://doi.org/10.15829/1728-8800-2024-4000</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Mrsic Z, Mousavi N, Hulten E, Bittencourt MS. The Prognostic Value of Late Gadolinium Enhancement in Nonischemic Heart Disease. Magn Reson Imaging Clin N Am. 2019 Aug;27(3):545-561. https://doi.org/10.1016/j.mric.2019.04.010</mixed-citation><mixed-citation xml:lang="en">Mrsic Z, Mousavi N, Hulten E, Bittencourt MS. The Prognostic Value of Late Gadolinium Enhancement in Nonischemic Heart Disease. Magn Reson Imaging Clin N Am. 2019 Aug;27(3):545-561. https://doi.org/10.1016/j.mric.2019.04.010</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Марченко Д.С., Александрова С.А., Глазкова Е.Ю., и соавт. Определение диапазона референсных значений нативного времени Т1-, Т2-релаксации миокарда параметрических карт в модификации MOLLY на магнитно-резонансной томографии 1,5 Тл. Креативная кардиология. 2024;18(1):36-43. https://doi.org/10.24022/1997-3187-2</mixed-citation><mixed-citation xml:lang="en">Marchenko D.S., Alexandrova S.A., Glazkova E.Yu., et al. Determination of reference ranges for native myocardial T1 and T2 relaxation times using MOLLI-based parametric mapping on 1.5T MRI. Creative Cardiology. 2024;18(1):36-43. (In Russ.) https://doi.org/10.24022/1997-3187-2</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Haaf P., Garg P., Messroghli D.R., et al. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. Journal of Cardiovascular Magnetic Resonance. 2016;18(1):89. https://doi.org/10.1186/s12968-016-0308-4</mixed-citation><mixed-citation xml:lang="en">Haaf P., Garg P., Messroghli D.R., et al. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. Journal of Cardiovascular Magnetic Resonance. 2016;18(1):89. https://doi.org/10.1186/s12968-016-0308-4</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Голухова Е.З., Александрова С.А., Булаева Н.И., и соавт. Прогностическая роль показателей деформации миокарда по данным магнитно-резонансной томографии при неишемических дилатационных кардиомиопатиях: систематический обзор и мета-анализ. Кардиология. 2022;62(10):35–41. https://doi.org/10.18087/cardio.2022.10.n2034</mixed-citation><mixed-citation xml:lang="en">Golukhova E.Z., Alexandrova S.A., Bulaeva N.I., et al. Prognostic role of myocardial deformation parameters assessed by magnetic resonance imaging in non-ischemic dilated cardiomyopathy: a systematic review and meta-analysis. Kardiologiia. 2022;62(10):35– 41. (In Russ.) https://doi.org/10.18087/cardio.2022.10.n2034</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Daniel T. Ginat, Michael W. Fong, et al. Cardiac Imaging: Part 1, MR Pulse Sequences, Imaging Planes, and Basic Anatomy. AJR Am J Roentgenol. 2011 Oct;197(4):808-15. https://doi.org/10.2214/AJR.10.7231</mixed-citation><mixed-citation xml:lang="en">Daniel T. Ginat, Michael W. Fong, et al. Cardiac Imaging: Part 1, MR Pulse Sequences, Imaging Planes, and Basic Anatomy. AJR Am J Roentgenol. 2011 Oct;197(4):808-15. https://doi.org/10.2214/AJR.10.7231</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Rao SV, O’Donoghue ML, Ruel M, et al. 2025 ACC/AHA/ACEP/ NAEMSP/SCAI Guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;151:e771-e862. https://doi.org/10.1161/CIR.0000000000001309</mixed-citation><mixed-citation xml:lang="en">Rao SV, O’Donoghue ML, Ruel M, et al. 2025 ACC/AHA/ACEP/ NAEMSP/SCAI Guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;151:e771-e862. https://doi.org/10.1161/CIR.0000000000001309</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019 Jan 14;40(3):237-269. https://doi.org/10.1093/eurheartj/ehy462</mixed-citation><mixed-citation xml:lang="en">Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019 Jan 14;40(3):237-269. https://doi.org/10.1093/eurheartj/ehy462</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Jun Takahashi, Sho Onuma, Kiyotaka Hao, et al. Pathophysiology and diagnostic pathway of myocardial infarction with non-obstructive coronary arteries. Journal of Cardiology 2024:83(1):17–24, https://doi.org/10.1016/j.jjcc.2023.07.014</mixed-citation><mixed-citation xml:lang="en">Jun Takahashi, Sho Onuma, Kiyotaka Hao, et al. Pathophysiology and diagnostic pathway of myocardial infarction with non-obstructive coronary arteries. Journal of Cardiology 2024:83(1):17–24, https://doi.org/10.1016/j.jjcc.2023.07.014</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. Cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology: a comprehensive summary and update. J Cardiovasc Magn Reson. 2023 Jul 24;25(1):42. https://doi.org/10.1186/s12968-023-00950-z</mixed-citation><mixed-citation xml:lang="en">von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. Cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology: a comprehensive summary and update. J Cardiovasc Magn Reson. 2023 Jul 24;25(1):42. https://doi.org/10.1186/s12968-023-00950-z</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Tornvall P, Gerbaud E, Behaghel A et al. Myocarditis or “true” infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coron ary disease: A meta-analysis of individual data regarding prevalence and risk markers for myocarditis and infarction determined by cardiac magnetic resonance imaging in myocardial infarction with nonobstructive coronary artery disease. Atherosclerosis 2015;241:87- 91. https://doi.org/10.1016/j.atherosclerosis.2015.04.816</mixed-citation><mixed-citation xml:lang="en">Tornvall P, Gerbaud E, Behaghel A et al. Myocarditis or “true” infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coron ary disease: A meta-analysis of individual data regarding prevalence and risk markers for myocarditis and infarction determined by cardiac magnetic resonance imaging in myocardial infarction with nonobstructive coronary artery disease. Atherosclerosis 2015;241:87- 91. https://doi.org/10.1016/j.atherosclerosis.2015.04.816</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Vago H, Szabo L, Horvath V et al. Differential diagnosis of MINOCA patients: the contribution of early cardiac magnetic resonance imaging to the final diagnosis in patients with normal coronary angiography. Eur Heart J 2019; 40, Issue Supplement_1. https://doi.org/10.1093/eurheartj/ehz748.0146</mixed-citation><mixed-citation xml:lang="en">Vago H, Szabo L, Horvath V et al. Differential diagnosis of MINOCA patients: the contribution of early cardiac magnetic resonance imaging to the final diagnosis in patients with normal coronary angiography. Eur Heart J 2019; 40, Issue Supplement_1. https://doi.org/10.1093/eurheartj/ehz748.0146</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Тереничева М.А., Шахнович Р.М., Стукалова О.В., Буторова Е.А., Терновой С.К. Взаимосвязь структурных изменений миокарда у больных острым инфарктом миокарда с подъемом сегмента ST по данным контрастной МРТ с особенностями коронарного поражения и временем реперфузионной терапии. Российский электронный журнал лучевой диагностики. 2021;11(1):114– 124. https://doi.org/10.21569/2222-7415-2021-11-1-114-124</mixed-citation><mixed-citation xml:lang="en">Terenicheva M.A., Shakhnovich R.M., Stukalova O.V., Butorova E.A., Ternovoy S.K. Relationship between myocardial structural changes in patients with ST-segment elevation acute myocardial infarction (assessed by contrast-enhanced MRI) and the characteristics of coronary artery lesions and timing of reperfusion therapy. Russian Electronic Journal of Radiology. 2021;11(1):114–124. (In Russ.) https://doi.org/10.21569/2222-7415-2021-11-1-114-124</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Richard E. Jones, Hassan A. Zaidi, Daniel J. Hammersley, et al. Comprehensive Phenotypic Characterization of Late Gadolinium Enhancement Predicts Sudden Cardiac Death in Coronary Artery Disease. JACC: Cardiovascular Imaging. 2023.16(5):628-638. https://www.jacc.org/doi/10.1016/j.jcmg.2022.10.020</mixed-citation><mixed-citation xml:lang="en">Richard E. Jones, Hassan A. Zaidi, Daniel J. Hammersley, et al. Comprehensive Phenotypic Characterization of Late Gadolinium Enhancement Predicts Sudden Cardiac Death in Coronary Artery Disease. JACC: Cardiovascular Imaging. 2023.16(5):628-638. https://www.jacc.org/doi/10.1016/j.jcmg.2022.10.020</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Карпов Ю.А., Барбараш О.Л., Бощенко А.А., и соавт. Евразийские клинические рекомендации по диагностике и лечению стабильной ишемической болезни сердца (2020-2021). Евразийский кардиологический журнал. 2021;(3):54-93, https://doi.org/10.38109/2225-1685-2021-3-54-93</mixed-citation><mixed-citation xml:lang="en">Карпов Ю.А., Барбараш О.Л., Бощенко А.А., и соавт. Евразийские клинические рекомендации по диагностике и лечению стабильной ишемической болезни сердца (2020-2021). Евразийский кардиологический журнал. 2021;(3):54-93, https://doi.org/10.38109/2225-1685-2021-3-54-93</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Барбараш О.Л., Карпов Ю.А., Панов А.В., и соавт. Стабильная ишемическая болезнь сердца. Клинические рекомендации 2024. Российский кардиологический журнал. 2024;29(9):6110. https://doi.org/10.15829/1560-4071-2024-6110</mixed-citation><mixed-citation xml:lang="en">Barbarash O.L., Karpov Yu.A., Panov A.V., Akchurin R.S. et al. 2024 Clinical practice guidelines for Stable coronary artery disease. Russian Journal of Cardiology. 2024;29(9):6110. (In Russ.) https://doi.org/10.15829/1560-4071-2024-6110</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Nagel E, Greenwood JP, McCann GP, et al. Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease. N Engl J Med. 2019;380(25):2418-2428. https://doi.org/10.1056/NEJMoa1716734</mixed-citation><mixed-citation xml:lang="en">Nagel E, Greenwood JP, McCann GP, et al. Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease. N Engl J Med. 2019;380(25):2418-2428. https://doi.org/10.1056/NEJMoa1716734</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Lipinski MJ, McVey CM, Berger JS, Kramer CM, Salerno M. Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis. J Am Coll Cardiol. 2013;62(9):826-838. https://doi.org/10.1016/j.jacc.2013.03.080</mixed-citation><mixed-citation xml:lang="en">Lipinski MJ, McVey CM, Berger JS, Kramer CM, Salerno M. Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis. J Am Coll Cardiol. 2013;62(9):826-838. https://doi.org/10.1016/j.jacc.2013.03.080</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100(19):1992-2002. https://doi.org/10.1161/01.cir.100.19.1992</mixed-citation><mixed-citation xml:lang="en">Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100(19):1992-2002. https://doi.org/10.1161/01.cir.100.19.1992</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Gerber BL, Rousseau MF, Ahn SA, et al. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy. J Am Coll Cardiol. 2012;59(9):825-835. https://doi.org/10.1016/j.jacc.2011.09.073</mixed-citation><mixed-citation xml:lang="en">Gerber BL, Rousseau MF, Ahn SA, et al. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy. J Am Coll Cardiol. 2012;59(9):825-835. https://doi.org/10.1016/j.jacc.2011.09.073</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Klem I, Weinsaft JW, Bahnson TD, et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol. 2012;60(5):408-420. https://doi.org/10.1016/j.jacc.2012.02.070</mixed-citation><mixed-citation xml:lang="en">Klem I, Weinsaft JW, Bahnson TD, et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol. 2012;60(5):408-420. https://doi.org/10.1016/j.jacc.2012.02.070</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt A, Azevedo CF, Cheng A, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007;115(15):2006-2014. https://doi.org/10.1161/CIRCULATIONAHA.106.653568</mixed-citation><mixed-citation xml:lang="en">Schmidt A, Azevedo CF, Cheng A, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007;115(15):2006-2014. https://doi.org/10.1161/CIRCULATIONAHA.106.653568</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Yan AT, Shayne AJ, Brown KA, et al. Characterization of the periinfarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation. 2006;114(1):32-39. https://doi.org/10.1161/CIRCULATIONAHA.106.613414</mixed-citation><mixed-citation xml:lang="en">Yan AT, Shayne AJ, Brown KA, et al. Characterization of the periinfarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation. 2006;114(1):32-39. https://doi.org/10.1161/CIRCULATIONAHA.106.613414</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Михайлов Е.Н., Гизатулина Т.П., Лебедев Д.С., Голухова Е.З. и др. Желудочковые нарушения ритма сердца. Внезапная сердечная смерть. Клинические рекомендации 2025. Российский кардиологический журнал. 2025;30(11):6670. https://doi.org/10.15829/1560-4071-2025-6670</mixed-citation><mixed-citation xml:lang="en">Mikhailov E.N., Gizatulina T.P., Lebedev D.S., Golukhova E.Z., et al. 2025 Clinical practice guidelines for Ventricular arrhythmias of the heart and Sudden cardiac death. Russian Journal of Cardiology. 2025;30(11):6670. (In Russ.) https://doi.org/10.15829/1560-4071-2025-6670</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Голицын С.П., Панченко Е.П., Миронов Н.Ю., и др. Евразийские клинические рекомендации по диагностике и лечению фибрилляции предсердий у взрослых (2025). Евразийский кардиологический журнал. 2025;(3):6–77. https://doi.org/10.38109/2225-1685-2025-3-6-77</mixed-citation><mixed-citation xml:lang="en">Golitsyn S.P., Panchenko E.P., Mironov N.Yu., et al. Eurasian clinical guidelines for the diagnosis and treatment of atrial fibrillation in adult patients (2025). Eurasian heart journal. 2025;(3):6-77. (In Russ.) https://doi.org/10.38109/2225-1685-2025-3-6-77</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Голухова Е.З. Отчет по работе Главного внештатного специалиста кардиолога-аритмолога Минздрава России за 2020 год. [Электронный ресурс]. URL: https://static0.minzdrav.gov.ru/system/attachments/attaches/000/056/600/original/Отчет_за_2020_год_Голухова.pdf?1624888958</mixed-citation><mixed-citation xml:lang="en">Golukhova E.Z. Report on the activities of the Chief Freelance Specialist in Cardiology and Arrhythmology of the Ministry of Health of Russia for 2020. [Electronic resource]. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Tom Nelson, Pankaj Garg, Richard H Clayton, and Justin Lee. The Role of Cardiac MRI in the Management of Ventricular Arrhythmias in Ischaemic and Non-ischaemic Dilated Cardiomyopathy. Arrhythmia &amp; Electrophysiology Review 2019;8(3):191–201. https://doi.org/10.15420/aer.2019.5.1.</mixed-citation><mixed-citation xml:lang="en">Tom Nelson, Pankaj Garg, Richard H Clayton, and Justin Lee. The Role of Cardiac MRI in the Management of Ventricular Arrhythmias in Ischaemic and Non-ischaemic Dilated Cardiomyopathy. Arrhythmia &amp; Electrophysiology Review 2019;8(3):191–201. https://doi.org/10.15420/aer.2019.5.1.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al.; ESC Scientific Document Group. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022 Oct 21;43(40):3997-4126. PMID: 36017572. https://doi.org/10.1093/eurheartj/ehac262</mixed-citation><mixed-citation xml:lang="en">Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al.; ESC Scientific Document Group. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022 Oct 21;43(40):3997-4126. PMID: 36017572. https://doi.org/10.1093/eurheartj/ehac262</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Muser D, Santangeli P, Selvanayagam JB, Nucifora G. Role of Cardiac Magnetic Resonance Imaging in Patients with Idiopathic Ventricular Arrhythmias. Curr Cardiol Rev. 2019;15(1):12-23. https://doi.org/10.2174/1573403X14666180925095923</mixed-citation><mixed-citation xml:lang="en">Muser D, Santangeli P, Selvanayagam JB, Nucifora G. Role of Cardiac Magnetic Resonance Imaging in Patients with Idiopathic Ventricular Arrhythmias. Curr Cardiol Rev. 2019;15(1):12-23. https://doi.org/10.2174/1573403X14666180925095923</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Andreini D, Dello Russo A, Pontone G, Mushtaq S, Conte E, Perchinunno M, Guglielmo M, Coutinho Santos A, Magatelli M, Baggiano A, Zanchi S, Melotti E, Fusini L, Gripari P, Casella M, Carbucicchio C, Riva S, Fassini G, Li Piani L, Fiorentini C, Bartorelli AL, Tondo C, Pepi M. CMR for Identifying the Substrate of Ventricular Arrhythmia in Patients With Normal Echocardiography. JACC Cardiovasc Imaging. 2020 Feb;13(2 Pt 1):410-421. https://doi.org/10.1016/j.jcmg.2019.04.023</mixed-citation><mixed-citation xml:lang="en">Andreini D, Dello Russo A, Pontone G, Mushtaq S, Conte E, Perchinunno M, Guglielmo M, Coutinho Santos A, Magatelli M, Baggiano A, Zanchi S, Melotti E, Fusini L, Gripari P, Casella M, Carbucicchio C, Riva S, Fassini G, Li Piani L, Fiorentini C, Bartorelli AL, Tondo C, Pepi M. CMR for Identifying the Substrate of Ventricular Arrhythmia in Patients With Normal Echocardiography. JACC Cardiovasc Imaging. 2020 Feb;13(2 Pt 1):410-421. https://doi.org/10.1016/j.jcmg.2019.04.023</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">White JA, Fine NM, Gula L, Yee R, Skanes A, Klein G, LeongSit P, Warren H, Thompson T, Drangova M, Krahn A. Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias. Circ Cardiovasc Imaging. 2012 Jan;5(1):12-20. https://doi.org/10.1161/CIRCIMAGING.111.966085</mixed-citation><mixed-citation xml:lang="en">White JA, Fine NM, Gula L, Yee R, Skanes A, Klein G, LeongSit P, Warren H, Thompson T, Drangova M, Krahn A. Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias. Circ Cardiovasc Imaging. 2012 Jan;5(1):12-20. https://doi.org/10.1161/CIRCIMAGING.111.966085</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Reithmann C, Herkommer B, Fiek M. Epicardial ventricular tachycardia substrate visualized by magnetic resonance imaging: need for a transpericardial ablation approach? Clin Res Cardiol. 2016 Oct;105(10):827-37. https://doi.org/10.1007/s00392-016-0990-0</mixed-citation><mixed-citation xml:lang="en">Reithmann C, Herkommer B, Fiek M. Epicardial ventricular tachycardia substrate visualized by magnetic resonance imaging: need for a transpericardial ablation approach? Clin Res Cardiol. 2016 Oct;105(10):827-37. https://doi.org/10.1007/s00392-016-0990-0</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Pattanayak P, Bleumke DA. Tissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imaging. Radiol Clin North Am. 2015 Mar;53(2):413-23. https://doi.org/10.1016/j.rcl.2014.11.005</mixed-citation><mixed-citation xml:lang="en">Pattanayak P, Bleumke DA. Tissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imaging. Radiol Clin North Am. 2015 Mar;53(2):413-23. https://doi.org/10.1016/j.rcl.2014.11.005</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Aljaroudi WA, Flamm SD, Saliba W, Wilkoff BL, Kwon D. Role of CMR imaging in risk stratification for sudden cardiac death. JACC Cardiovasc Imaging. 2013 Mar;6(3):392-406. https://doi.org/10.1016/j.jcmg.2012.11.011</mixed-citation><mixed-citation xml:lang="en">Aljaroudi WA, Flamm SD, Saliba W, Wilkoff BL, Kwon D. Role of CMR imaging in risk stratification for sudden cardiac death. JACC Cardiovasc Imaging. 2013 Mar;6(3):392-406. https://doi.org/10.1016/j.jcmg.2012.11.011</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Бердибеков Б.Ш., Александрова С.А., Громова О.И., Меладзе М.Г., Голухова Е.З. Прогностическая роль магнитно-резонансной томографии при некоронарогенных желудочковых аритмиях. Креативная кардиология. 2022;16(2):199-215.</mixed-citation><mixed-citation xml:lang="en">Berdibekov B.Sh., Alexandrova S.A., Gromova O.I., Meladze M.G., Golukhova E.Z. Prognostic role of magnetic resonance imaging in non-coronary ventricular arrhythmias. Creative Cardiology. 2022;16(2):199-215. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">4 Van Gelder IC, Rienstra M, Bunting KV, et al.; ESC Scientific Document Group. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024 Sep 29;45(36):3314-3414. https://doi.org/10.1093/eurheartj/ehae176. Erratum in: Eur Heart J. 2025 Nov 3;46(41):4349. PMID: 39210723. https://doi.org/10.1093/eurheartj/ehaf306</mixed-citation><mixed-citation xml:lang="en">4 Van Gelder IC, Rienstra M, Bunting KV, et al.; ESC Scientific Document Group. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024 Sep 29;45(36):3314-3414. https://doi.org/10.1093/eurheartj/ehae176. Erratum in: Eur Heart J. 2025 Nov 3;46(41):4349. PMID: 39210723. https://doi.org/10.1093/eurheartj/ehaf306</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Vira T, Pechlivanoglou P, Connelly K, Wijeysundera HC, Roifman I. Cardiac computed tomography and magnetic resonance imaging vs. transoesophageal echo- cardiography for diagnosing left atrial appendage thrombi. Europace. 2019;21(1):e1–e10. https://doi.org/10.1093/europace/euy142</mixed-citation><mixed-citation xml:lang="en">Vira T, Pechlivanoglou P, Connelly K, Wijeysundera HC, Roifman I. Cardiac computed tomography and magnetic resonance imaging vs. transoesophageal echo- cardiography for diagnosing left atrial appendage thrombi. Europace. 2019;21(1):e1–e10. https://doi.org/10.1093/europace/euy142</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, Deneke T, Duytschaever M, Neumann T, Mansour M, Mahnkopf C, Herweg B, Daoud E, Wissner E, Bansmann P, Brachmann J. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014 Feb 5;311(5):498-506. Erratum in: JAMA. 2014 Nov 5;312(17):1805. PMID: 24496537. https://doi.org/10.1001/jama.2014.3</mixed-citation><mixed-citation xml:lang="en">Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, Deneke T, Duytschaever M, Neumann T, Mansour M, Mahnkopf C, Herweg B, Daoud E, Wissner E, Bansmann P, Brachmann J. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014 Feb 5;311(5):498-506. Erratum in: JAMA. 2014 Nov 5;312(17):1805. PMID: 24496537. https://doi.org/10.1001/jama.2014.3</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Шишкина Н.М., Сергуладзе С.Ю., Александрова С.А., Сопов О.В., и соавт. Электрофизиологические и структурные особенности миокарда левого предсердия у пожилых людей с признаками старческой астении и пароксизмальной формой фибрилляции предсердий. Анналы аритмологии. 2023;20(4):258-266. https://doi.org/10.15275/annaritmol.2023.4.6</mixed-citation><mixed-citation xml:lang="en">Shishkina N.M., Serguladze S.Yu., Aleksandrova S.A., Sopov O.V., et al. Electrophysiological and structural characteristics of the left atrial myocardium in elderly patients with signs of frailty and paroxysmal atrial fibrillation. Annals of Arrhythmology. 2023;20(4):258-266. (In Russ.) https://doi.org/10.15275/annaritmol.2023.4.6</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Пахоменко П.К., Апарина О.П., Стукалова О.В., Майков Е.Б. Сравнение результатов высокоплотного электроанатомического картирования левого предсердия и структуры левого предсердия по данным магнитно-резонансной томографии высокого разрешения с отсроченным контрастированием при фибрилляции предсердий. Кардиологический вестник. 2024;19(2- 2):226-227.</mixed-citation><mixed-citation xml:lang="en">Pakhomenko P.K., Aparina O.P., Stukalova O.V., Maykov E.B. Comparison of high-density electroanatomical mapping results of the left atrium and left atrial structure based on high-resolution delayedenhancement magnetic resonance imaging in atrial fibrillation. Kardiologicheskiy Vestnik. 2024;19(2-2):226-227. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao Y, Dagher L, Huang C, Miller P, Marrouche NF. Cardiac MRI to Manage Atrial Fibrillation. Arrhythm Electrophysiol Rev. 2020 Dec;9(4):189-194. https://doi.org/10.15420/aer.2020.21</mixed-citation><mixed-citation xml:lang="en">Zhao Y, Dagher L, Huang C, Miller P, Marrouche NF. Cardiac MRI to Manage Atrial Fibrillation. Arrhythm Electrophysiol Rev. 2020 Dec;9(4):189-194. https://doi.org/10.15420/aer.2020.21</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Marrouche NF, Wazni O, McGann C, Greene T, Dean JM, Dagher L, Kholmovski E, Mansour M, Marchlinski F, Wilber D, Hindricks G, Mahnkopf C, Wells D, Jais P, Sanders P, Brachmann J, Bax JJ, Morrison-de Boer L, Deneke T, Calkins H, Sohns C, Akoum N; DECAAF II Investigators. Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial. JAMA. 2022 Jun 21;327(23):2296-2305. https://doi.org/10.1001/jama.2022.8831</mixed-citation><mixed-citation xml:lang="en">Marrouche NF, Wazni O, McGann C, Greene T, Dean JM, Dagher L, Kholmovski E, Mansour M, Marchlinski F, Wilber D, Hindricks G, Mahnkopf C, Wells D, Jais P, Sanders P, Brachmann J, Bax JJ, Morrison-de Boer L, Deneke T, Calkins H, Sohns C, Akoum N; DECAAF II Investigators. Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial. JAMA. 2022 Jun 21;327(23):2296-2305. https://doi.org/10.1001/jama.2022.8831</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Абгарян А.А., Бердибеков Б.Ш., Александрова С.А. и соав. Прогностическая роль оценки фиброза левого предсердия по данным магнитно-резонансной томографии у пациентов с фибрилляцией предсердий, перенесших катетерную изоляцию легочных вен. Креативная кардиология. 2024;18(1):92–103.</mixed-citation><mixed-citation xml:lang="en">Abgaryan A.A., Berdibekov B.Sh., Alexandrova S.A., et al. Prognostic role of left atrial fibrosis assessment by magnetic resonance imaging in patients with atrial fibrillation who underwent catheter isolation of pulmonary veins. Creative Cardiology. 2024;18(1):92– 103. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Laubrock K, von Loesch T, Steinmetz M, et al. Imaging of arrhythmia: real-time cardiac magnetic resonance imaging in atrial fibrillation. Eur J Radiol Open 2022;9:100404. https://doi.org/10.1016/j.ejro.2022.100404</mixed-citation><mixed-citation xml:lang="en">Laubrock K, von Loesch T, Steinmetz M, et al. Imaging of arrhythmia: real-time cardiac magnetic resonance imaging in atrial fibrillation. Eur J Radiol Open 2022;9:100404. https://doi.org/10.1016/j.ejro.2022.100404</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Chen J, Zhang H, Zhu D, et al. Cardiac MRI for detecting left atrial/ left atrial ap- pendage thrombus in patients with atrial fibrillation: meta-analysis and systematic review. Herz. 2019;44(5):390-397. https://doi.org/10.1007/s00059-017-4676-9</mixed-citation><mixed-citation xml:lang="en">Chen J, Zhang H, Zhu D, et al. Cardiac MRI for detecting left atrial/ left atrial ap- pendage thrombus in patients with atrial fibrillation: meta-analysis and systematic review. Herz. 2019;44(5):390-397. https://doi.org/10.1007/s00059-017-4676-9</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Taki H, Tuomilehto J, Zimmet P, et al. Left ventricular hypertrophy: an ECG-based study of prevalence and risk factors in a multiethnic population. Open Heart. 2023;10:e002495. https://doi.org/10.1136/openhrt-2023-002495</mixed-citation><mixed-citation xml:lang="en">Taki H, Tuomilehto J, Zimmet P, et al. Left ventricular hypertrophy: an ECG-based study of prevalence and risk factors in a multiethnic population. Open Heart. 2023;10:e002495. https://doi.org/10.1136/openhrt-2023-002495</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Grajewski KG, Stojanovska J, Ibrahim EH, Sayyouh M, Attili A. Left Ventricular Hypertrophy: Evaluation With Cardiac MRI. Curr Probl Diagn Radiol. 2020 Nov-Dec;49(6):460-475. https://doi.org/10.1067/j.cpradiol.2019.09.005</mixed-citation><mixed-citation xml:lang="en">Grajewski KG, Stojanovska J, Ibrahim EH, Sayyouh M, Attili A. Left Ventricular Hypertrophy: Evaluation With Cardiac MRI. Curr Probl Diagn Radiol. 2020 Nov-Dec;49(6):460-475. https://doi.org/10.1067/j.cpradiol.2019.09.005</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Терещенко С.Н., Жиров И.В., Ускач Т.М., и соавт. Клинические рекомендации Евразийской ассоциации кардиологов (ЕАК)/ Национальное общество специалистов по заболеваниям миокарда и сердечной недостаточности (НОИСН) по диагностике и лечению хронической сердечной недостаточности (2020). Евразийский кардиологический журнал. 2020;(3):6-76. https://doi.org/10.38109/2225-1685-2020-3-6-76</mixed-citation><mixed-citation xml:lang="en">Tereshchenko S.N., Zhirov I.V., Uskach T.M., Saidova M.A., Golitsyn S.P., Gupalo E.M., Nasonova S.N., Narusov O.Yu., Safiullina A.A., Tereshchenko A.S., Stukalova O.V. Eurasian association of cardiology (EAC)/ National society of heart failure and myocardial disease (NSHFMD) guidelines for the diagnosis and treatment of chronic heart failure (2020). Eurasian heart journal. 2020;(3):6-76. (In Russ.) https://doi.org/10.38109/2225-1685-2020-3-6-76</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Фомин И. В. Артериальная гипертония в Российской Федерации — последние 10 лет. Что дальше? Сердце. 2007;6(3):1-6.</mixed-citation><mixed-citation xml:lang="en">Fomin IV. Arterial hypertension in the Russian Federation-the last 10 years. What’s next? Heart. 2007;6(3):1-6. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Ситникова М. Ю., Юрченко А. В., Лясникова Е. А., и др. Результаты Российского госпитального регистра хронической сердечной недостаточности в 3 субъектах Российской Федерации. Кардиология. 2015;55(10):5-13. https://doi.org/10.18565/cardio.2015.10.5-13</mixed-citation><mixed-citation xml:lang="en">Sitnikova MYu, Lyasnikova EA, Yurchenko AV, et al. The results of the Russian hospital register of chronic heart failure in 3 regions of the Russian Federation. Kardiologija. 2015;55(10):5-13. (In Russ.) https://doi.org/10.18565/cardio.2015.10.5-13</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Уельхази У., Стукалова О.В., Терновой С.К. Магнитно-резонансная томография сердца в оценке структурных и функциональных изменений миокарда у больных с хронической сердечной недостаточностью. Евразийский Кардиологический Журнал. 2026;(1):54-63. https://doi.org/10.38109/2225-1685-2026-1-54-63</mixed-citation><mixed-citation xml:lang="en">Ouelhazi O., Stukalova O.V., Ternovoy S.K. MRI of the heart for the assessment of structural and functional changes in the myocardium in patients with chronic heart failure. Eurasian heart journal. 2026;(1):54-63. (In Russ.) https://doi.org/10.38109/2225-1685-2026-1-54-63</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Igolli M, Anandabaskaran S, Christiansen JP, Whalley GA. Bias associated with left ventricular quantification by multimodality imaging: a systematic review and meta-analysis. Open Heart 2016;3(1):e000388. https://doi.org/10.1136/openhrt-2015-000388</mixed-citation><mixed-citation xml:lang="en">Igolli M, Anandabaskaran S, Christiansen JP, Whalley GA. Bias associated with left ventricular quantification by multimodality imaging: a systematic review and meta-analysis. Open Heart 2016;3(1):e000388. https://doi.org/10.1136/openhrt-2015-000388</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Grothues F, Smith GC, Moon JC, et al. Comparison of inter-study reproducibility of cardiovascular magnetic resonance with twodimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002;90(1):29–34. https://doi.org/10.1016/s0002-9149(02)02381-0</mixed-citation><mixed-citation xml:lang="en">Grothues F, Smith GC, Moon JC, et al. Comparison of inter-study reproducibility of cardiovascular magnetic resonance with twodimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002;90(1):29–34. https://doi.org/10.1016/s0002-9149(02)02381-0</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Muiesan ML, de Simone G, Ganau A, et al. Inappropriate left ventricular mass: reliability and limitations of echocardiographic measurement for risk stratification and follow-up in single patients. J Hypertens 2006;24(11):2293–8. https://doi.org/10.1097/01.hjh.0000249709.44016.15</mixed-citation><mixed-citation xml:lang="en">Muiesan ML, de Simone G, Ganau A, et al. Inappropriate left ventricular mass: reliability and limitations of echocardiographic measurement for risk stratification and follow-up in single patients. J Hypertens 2006;24(11):2293–8. https://doi.org/10.1097/01.hjh.0000249709.44016.15</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Papanastasiou CA, Kampaktsis PN, Bazmpani MA, Zegkos T, Efthimiadis G, Tsapas A, Ziakas A, Karamitsos TD. Diagnostic Accuracy of CMR With Late Gadolinium Enhancement for Ischemic Cardiomyopathy: A Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging. 2023 Mar;16(3):399-401. https://doi.org/10.1016/j.jcmg.2022.12.024</mixed-citation><mixed-citation xml:lang="en">Papanastasiou CA, Kampaktsis PN, Bazmpani MA, Zegkos T, Efthimiadis G, Tsapas A, Ziakas A, Karamitsos TD. Diagnostic Accuracy of CMR With Late Gadolinium Enhancement for Ischemic Cardiomyopathy: A Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging. 2023 Mar;16(3):399-401. https://doi.org/10.1016/j.jcmg.2022.12.024</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Kuruvilla S, Adenaw N, Katwal AB, et al. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis. Circ Cardiovasc Imaging 2014;7(2):250–8. https://doi.org/10.1161/CIRCIMAGING.113.001144</mixed-citation><mixed-citation xml:lang="en">Kuruvilla S, Adenaw N, Katwal AB, et al. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis. Circ Cardiovasc Imaging 2014;7(2):250–8. https://doi.org/10.1161/CIRCIMAGING.113.001144</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Becker MAJ, Cornel JH, van de Ven PM, et al. The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and metaanalysis. JACC Cardiovasc Imaging 2018;11(9):1274–84. https://doi.org/10.1016/j.jcmg.2018.03.006.</mixed-citation><mixed-citation xml:lang="en">Becker MAJ, Cornel JH, van de Ven PM, et al. The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and metaanalysis. JACC Cardiovasc Imaging 2018;11(9):1274–84. https://doi.org/10.1016/j.jcmg.2018.03.006.</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 2018;72(24):3158–76. https://doi.org/10.1016/j.jacc.2018.09.072</mixed-citation><mixed-citation xml:lang="en">Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 2018;72(24):3158–76. https://doi.org/10.1016/j.jacc.2018.09.072</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/ HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022;145(18):e895–1032. https://doi.org/10.1161/cir.0000000000001063</mixed-citation><mixed-citation xml:lang="en">Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/ HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022;145(18):e895–1032. https://doi.org/10.1161/cir.0000000000001063</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">Chamsi-Pasha MA, Zhan Y, Debs D, Shah DJ. CMR in the evaluation of diastolic dysfunction and phenotyping of HFpEF: current role and future perspectives. JACC Cardiovasc Imaging 2020;13(1 Pt 2):283–96. https://doi.org/10.1016/j.jcmg.2019.02.031</mixed-citation><mixed-citation xml:lang="en">Chamsi-Pasha MA, Zhan Y, Debs D, Shah DJ. CMR in the evaluation of diastolic dysfunction and phenotyping of HFpEF: current role and future perspectives. JACC Cardiovasc Imaging 2020;13(1 Pt 2):283–96. https://doi.org/10.1016/j.jcmg.2019.02.031</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">Iles L, Pfluger H, Lefkovits L, et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverterdefibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011 Feb 15;57(7):821-8. https://doi.org/10.1016/j.jacc.2010.06.062</mixed-citation><mixed-citation xml:lang="en">Iles L, Pfluger H, Lefkovits L, et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverterdefibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011 Feb 15;57(7):821-8. https://doi.org/10.1016/j.jacc.2010.06.062</mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru">Harb SC, Toro S, Bullen JA, Obuchowski NA, Xu B, Trulock KM, et al. Scar burden is an independent and incremental predictor of cardiac resynchronisation therapy response. Open Heart 2019;6(2):e001067. https://doi.org/10.1136/openhrt-2019-001067</mixed-citation><mixed-citation xml:lang="en">Harb SC, Toro S, Bullen JA, Obuchowski NA, Xu B, Trulock KM, et al. Scar burden is an independent and incremental predictor of cardiac resynchronisation therapy response. Open Heart 2019;6(2):e001067. https://doi.org/10.1136/openhrt-2019-001067</mixed-citation></citation-alternatives></ref><ref id="cit94"><label>94</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Мартынюк Т.В., Шмальц А.А и соавт. Евразийские рекомендации по диагностике и лечению лёгочной гипертензии (2023). Евразийский Кардиологический Журнал. 2024;(1):6-85. https://doi.org/10.38109/2225-1685-2024-1-6-85</mixed-citation><mixed-citation xml:lang="en">Chazova I.E., Martynyuk T.V., Shmalts A.A., et al. Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension (2023). Eurasian heart journal. 2024;(1):6-85. (In Russ.) https://doi.org/10.38109/2225-1685-2024-1-6-85]</mixed-citation></citation-alternatives></ref><ref id="cit95"><label>95</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Горбачевский С.В., Мартынюк Т.В., и соавт. Евразийские рекомендации по диагностике и лечению легочной гипертензии, ассоциированной с врожденными пороками сердца у взрослых (2021). Евразийский Кардиологический Журнал. 2022;(2):6-70. https://doi.org/10.38109/2225-1685-2022-2-6-70</mixed-citation><mixed-citation xml:lang="en">Chazova I.E., Gorbachevskij S.V., Martynyuk T.V., et al. Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart defects in adults (2021). Eurasian heart journal. 2022;(2):6-70. (In Russ.) https://doi.org/10.38109/2225-1685-2022-2-6-70</mixed-citation></citation-alternatives></ref><ref id="cit96"><label>96</label><citation-alternatives><mixed-citation xml:lang="ru">Saunders LC, Hughes PJC, Alabed S, et al. Integrated Cardiopulmonary MRI Assessment of Pulmonary Hypertension. J Magn Reson Imaging 2022; 55(3): 633-52. PMID: 34350655. https://doi.org/10.1002/jmri.27849</mixed-citation><mixed-citation xml:lang="en">Saunders LC, Hughes PJC, Alabed S, et al. Integrated Cardiopulmonary MRI Assessment of Pulmonary Hypertension. J Magn Reson Imaging 2022; 55(3): 633-52. PMID: 34350655. https://doi.org/10.1002/jmri.27849</mixed-citation></citation-alternatives></ref><ref id="cit97"><label>97</label><citation-alternatives><mixed-citation xml:lang="ru">Alunni JP, Degano B, Arnaud C, et al. Cardiac MRI in pulmonary artery hypertension: correlations between morphological and functional parameters and invasive measurements. Eur Radiol 2010; 20(5): 1149-59. PMID: 20094890. http://doi.org/10.1007/s00330-009-1664-3</mixed-citation><mixed-citation xml:lang="en">Alunni JP, Degano B, Arnaud C, et al. Cardiac MRI in pulmonary artery hypertension: correlations between morphological and functional parameters and invasive measurements. Eur Radiol 2010; 20(5): 1149-59. PMID: 20094890. http://doi.org/10.1007/s00330-009-1664-3</mixed-citation></citation-alternatives></ref><ref id="cit98"><label>98</label><citation-alternatives><mixed-citation xml:lang="ru">Rajaram S, Swift AJ, Capener D, et al. Diagnostic accuracy of contrast-enhanced MR angiography and unenhanced proton MR imaging compared with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension. Eur Radiol 2012; 22(2): 310-7. PMID: 21887483. http://doi.org/10.1007/s00330-011-2252-x</mixed-citation><mixed-citation xml:lang="en">Rajaram S, Swift AJ, Capener D, et al. Diagnostic accuracy of contrast-enhanced MR angiography and unenhanced proton MR imaging compared with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension. Eur Radiol 2012; 22(2): 310-7. PMID: 21887483. http://doi.org/10.1007/s00330-011-2252-x</mixed-citation></citation-alternatives></ref><ref id="cit99"><label>99</label><citation-alternatives><mixed-citation xml:lang="ru">Шария А.М., Мартынюк Т. В. Клиническое течение и прогноз у пациентов с идиопатической легочной артериальной гипертензией по данным современных регистров. Кардиологический вестник. 2021;16(3):23-7</mixed-citation><mixed-citation xml:lang="en">Shariya AM, Martynyuk TV. Data of modern registries on clinical course and prognosis of patients with idiopathic pulmonary arterial hypertension. Russian Cardiology Bulletin. 2021;16(3):23-7 (in Russ.). http://doi.org/10.17116/Cardiobulletin20211603123</mixed-citation></citation-alternatives></ref><ref id="cit100"><label>100</label><citation-alternatives><mixed-citation xml:lang="ru">Шария М.А., Мартынюк Т.В., Устюжанин Д.В., Шария А.М., Резухина Е.А., Крохова М.Ю., Родненков О.В. Неинвазивный мониторинг эффективности специфической терапии у пациентов с легочной артериальной гипертензией. Евразийский Кардиологический Журнал. 2025;(3):118-123. https://doi.org/10.38109/2225-1685-2025-3-118-123</mixed-citation><mixed-citation xml:lang="en">Shariya M.A., Martynyuk T.V., Ustyuzhanin D.V., Shariya A.M., Rezukhina E.A., Krokhova M.Yu., Rodnenkov O.V. Non-invasive monitoring of specific therapy effectiveness in pulmonary arterial hypertension patients. Eurasian heart journal. 2025;(3):118-123. (In Russ.) https://doi.org/10.38109/2225-1685-2025-3-118-123]</mixed-citation></citation-alternatives></ref><ref id="cit101"><label>101</label><citation-alternatives><mixed-citation xml:lang="ru">Dellegrottaglie S, Sanz J, Poon M, et al. Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. Radiology. 2007;243(1):63- 9. https://doi.org/10.1148/radiol.2431060067</mixed-citation><mixed-citation xml:lang="en">Dellegrottaglie S, Sanz J, Poon M, et al. Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. Radiology. 2007;243(1):63- 9. https://doi.org/10.1148/radiol.2431060067</mixed-citation></citation-alternatives></ref><ref id="cit102"><label>102</label><citation-alternatives><mixed-citation xml:lang="ru">Freed BH, Gomberg-Maitland M, Chandra S, et al. Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension. J Cardiovasc Magn Reson 2012;14(1):14. PMID: 22296860. http://doi.org/10.1186/1532-429X-14-11</mixed-citation><mixed-citation xml:lang="en">Freed BH, Gomberg-Maitland M, Chandra S, et al. Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension. J Cardiovasc Magn Reson 2012;14(1):14. PMID: 22296860. http://doi.org/10.1186/1532-429X-14-11</mixed-citation></citation-alternatives></ref><ref id="cit103"><label>103</label><citation-alternatives><mixed-citation xml:lang="ru">Blyth KG, Groenning BA, Martin TN, et al. Contrast enhancedcardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 2005;26(19):1993-9. PMID: 15899927. http://doi.org/10.1093/eurheartj/ehi328</mixed-citation><mixed-citation xml:lang="en">Blyth KG, Groenning BA, Martin TN, et al. Contrast enhancedcardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 2005;26(19):1993-9. PMID: 15899927. http://doi.org/10.1093/eurheartj/ehi328</mixed-citation></citation-alternatives></ref><ref id="cit104"><label>104</label><citation-alternatives><mixed-citation xml:lang="ru">García-Álvarez A, García-Lunar I, Pereda D, et al. Association of myocardial T1-mapping CMR with hemodynamics and RV performance in pulmonary hypertension. JACC Cardiovasc Imaging 2015; 8(1): 76-82. PMID: 25592698. http://doi.org/10.1016/jjcmg.2014.08.012</mixed-citation><mixed-citation xml:lang="en">García-Álvarez A, García-Lunar I, Pereda D, et al. Association of myocardial T1-mapping CMR with hemodynamics and RV performance in pulmonary hypertension. JACC Cardiovasc Imaging 2015; 8(1): 76-82. PMID: 25592698. http://doi.org/10.1016/jjcmg.2014.08.012</mixed-citation></citation-alternatives></ref><ref id="cit105"><label>105</label><citation-alternatives><mixed-citation xml:lang="ru">Swift AJ, Wild JM, Nagle SK, et al. Quantitative MR imaging of pulmonary hypertension: A practical approach to the current state of the art. J Thorac Imaging. 2014;29(2):68-79. https://doi.org/10.1097/RTI.0000000000000079</mixed-citation><mixed-citation xml:lang="en">Swift AJ, Wild JM, Nagle SK, et al. Quantitative MR imaging of pulmonary hypertension: A practical approach to the current state of the art. J Thorac Imaging. 2014;29(2):68-79. https://doi.org/10.1097/RTI.0000000000000079</mixed-citation></citation-alternatives></ref><ref id="cit106"><label>106</label><citation-alternatives><mixed-citation xml:lang="ru">Lewis RA, Johns CS, Cogliano M, et al. Identification of cardiac magnetic resonance imaging thresholds for risk stratification in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2020;201:458-68. https://doi.org/10.1164/rccm.201909-1771OC</mixed-citation><mixed-citation xml:lang="en">Lewis RA, Johns CS, Cogliano M, et al. Identification of cardiac magnetic resonance imaging thresholds for risk stratification in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2020;201:458-68. https://doi.org/10.1164/rccm.201909-1771OC</mixed-citation></citation-alternatives></ref><ref id="cit107"><label>107</label><citation-alternatives><mixed-citation xml:lang="ru">Samer A, Yousef S, Pankaj G, et al. Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension. JACC: Cardiovasc Imag. 2021;14(5):931-42. https://doi.org/10.1016/j.jcmg.2020.08.013</mixed-citation><mixed-citation xml:lang="en">Samer A, Yousef S, Pankaj G, et al. Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension. JACC: Cardiovasc Imag. 2021;14(5):931-42. https://doi.org/10.1016/j.jcmg.2020.08.013</mixed-citation></citation-alternatives></ref><ref id="cit108"><label>108</label><citation-alternatives><mixed-citation xml:lang="ru">van der Bruggen CE, Handoko ML, Bogaard Harm J, et al. The Value of Hemodynamic Measurements or Cardiac MRI in the Follow-up of Patients With Idiopathic Pulmonary Arterial Hypertension. CHEST. 2021;159(4):1575-85. https://doi.org/10.1016/j.chest.2020.10.077</mixed-citation><mixed-citation xml:lang="en">van der Bruggen CE, Handoko ML, Bogaard Harm J, et al. The Value of Hemodynamic Measurements or Cardiac MRI in the Follow-up of Patients With Idiopathic Pulmonary Arterial Hypertension. CHEST. 2021;159(4):1575-85. https://doi.org/10.1016/j.chest.2020.10.077</mixed-citation></citation-alternatives></ref><ref id="cit109"><label>109</label><citation-alternatives><mixed-citation xml:lang="ru">Арутюнов Г.П., Драгунов Д.О., Жиров И.B., Моисеева О.М., и соавт. Миокардиты. Клинические рекомендации 2025. Российский кардиологический журнал. 2025;30(8):6458. EDN: YDUWYZ. https://doi.org/10.15829/1560-4071-2025-6458</mixed-citation><mixed-citation xml:lang="en">Arutyunov G.P., Dragunov D.O., Zhirov I.V., Moiseeva O.M., et al. Myocarditis. Clinical Guidelines 2025. Russian Journal of Cardiology. 2025;30(8):6458. (In Russ.) https://doi.org/10.15829/1560-4071-2025-6458</mixed-citation></citation-alternatives></ref><ref id="cit110"><label>110</label><citation-alternatives><mixed-citation xml:lang="ru">Abdel-Aty H, Boyé P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol. 2005;45(11):1815-22. https://doi.org/10.1016/j.jacc.2004.11.069</mixed-citation><mixed-citation xml:lang="en">Abdel-Aty H, Boyé P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol. 2005;45(11):1815-22. https://doi.org/10.1016/j.jacc.2004.11.069</mixed-citation></citation-alternatives></ref><ref id="cit111"><label>111</label><citation-alternatives><mixed-citation xml:lang="ru">Ammirati E, Moslehi JJ. Diagnosis and treatment of acute myocarditis: a review. JAMA 2023;329:1098–1113. https://doi.org/10.1001/jama.2023.3371</mixed-citation><mixed-citation xml:lang="en">Ammirati E, Moslehi JJ. Diagnosis and treatment of acute myocarditis: a review. JAMA 2023;329:1098–1113. https://doi.org/10.1001/jama.2023.3371</mixed-citation></citation-alternatives></ref><ref id="cit112"><label>112</label><citation-alternatives><mixed-citation xml:lang="ru">Luetkens JA, Homsi R, Dabir D et al. Comprehensive cardiac magnetic resonance for short-term follow-up in acute myocarditis. J Am Heart Assoc. 2016;5(7):e003603. https://doi.org/10.1161/JAHA.116.003603</mixed-citation><mixed-citation xml:lang="en">Luetkens JA, Homsi R, Dabir D et al. Comprehensive cardiac magnetic resonance for short-term follow-up in acute myocarditis. J Am Heart Assoc. 2016;5(7):e003603. https://doi.org/10.1161/JAHA.116.003603</mixed-citation></citation-alternatives></ref><ref id="cit113"><label>113</label><citation-alternatives><mixed-citation xml:lang="ru">Стукалова О.В., Гупало Е.М., Чумаченко П.В., и соавт. Возможности магнитно-резонансной томографии сердца с контрастированием в диагностике миокардита различного клинического течения. Терапевтический архив. 2019;91(4):28-36. https://doi.org/10.26442/00403660.2019.04.000078</mixed-citation><mixed-citation xml:lang="en">Stukalova O.V., Gupalo E.M., Chumachenko P.V., et al. The value of cardiovascular magnetic resonance in myocarditis with different clinical presentation. Therapeutic Archive. 2019;91(4):28–36. (In Russ.) https://doi.org/10.26442/00403660.2019.04.000078</mixed-citation></citation-alternatives></ref><ref id="cit114"><label>114</label><citation-alternatives><mixed-citation xml:lang="ru">Karim Hassan, Anton Doubell, Charles Kyriakakis. Comparing the findings and diagnostic sensitivity of cardiovascular magnetic resonance in biopsy confirmed acute myocarditis with infarct-like vs. heart failure presentation. Journal of Cardiovascular Magnetic Resonance. 2022;24:69. https://doi.org/10.1186/s12968-022-00903-y</mixed-citation><mixed-citation xml:lang="en">Karim Hassan, Anton Doubell, Charles Kyriakakis. Comparing the findings and diagnostic sensitivity of cardiovascular magnetic resonance in biopsy confirmed acute myocarditis with infarct-like vs. heart failure presentation. Journal of Cardiovascular Magnetic Resonance. 2022;24:69. https://doi.org/10.1186/s12968-022-00903-y</mixed-citation></citation-alternatives></ref><ref id="cit115"><label>115</label><citation-alternatives><mixed-citation xml:lang="ru">Thomas Aretz H (1987) Myocarditis: the Dallas criteria. Hum Pathol 18:619–624. https://doi.org/10.1016/S0046-8177(87)80363-5</mixed-citation><mixed-citation xml:lang="en">Thomas Aretz H (1987) Myocarditis: the Dallas criteria. Hum Pathol 18:619–624. https://doi.org/10.1016/S0046-8177(87)80363-5</mixed-citation></citation-alternatives></ref><ref id="cit116"><label>116</label><citation-alternatives><mixed-citation xml:lang="ru">Ismail TF, Hua A, Plein S et al (2022) The role of cardiovascular magnetic resonance in the evaluation of acute myocarditis and inflammatory cardiomyopathies in clinical practice—a comprehensive review. Eur Heart J Cardiovasc Imaging 23:450– 464. https://doi.org/10.1093/ehjci/jeac021</mixed-citation><mixed-citation xml:lang="en">Ismail TF, Hua A, Plein S et al (2022) The role of cardiovascular magnetic resonance in the evaluation of acute myocarditis and inflammatory cardiomyopathies in clinical practice—a comprehensive review. Eur Heart J Cardiovasc Imaging 23:450– 464. https://doi.org/10.1093/ehjci/jeac021</mixed-citation></citation-alternatives></ref><ref id="cit117"><label>117</label><citation-alternatives><mixed-citation xml:lang="ru">Baccouche H, Mahrholdt H, Meinhardt G, et al. Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. Eur Heart J. 2009;30(23):2869-79. https://doi.org/10.1093/eurheartj/ehp328</mixed-citation><mixed-citation xml:lang="en">Baccouche H, Mahrholdt H, Meinhardt G, et al. Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. Eur Heart J. 2009;30(23):2869-79. https://doi.org/10.1093/eurheartj/ehp328</mixed-citation></citation-alternatives></ref><ref id="cit118"><label>118</label><citation-alternatives><mixed-citation xml:lang="ru">Синицын В.Е., Стукалова О.В., Ларина О.М. и др. Новые возможности диагностики некоронарогенных поражений миокарда: роль магнитно-резонансной томографии. Креативная кардиология. 2008;(1):66-73. EDN: JZBNHT.</mixed-citation><mixed-citation xml:lang="en">Sinitsyn V.E., Stukalova O.V., Larina O.M., et al. New possibilities for diagnosing non-coronary myocardial lesions: the role of magnetic resonance imaging. Creative Cardiology. 2008;(1):66-73. (In Russ.) EDN: JZBNHT.</mixed-citation></citation-alternatives></ref><ref id="cit119"><label>119</label><citation-alternatives><mixed-citation xml:lang="ru">Jeanette Schulz-Menger, Valentino Collini, Jan Gröschel, et al. The ESC Scientific Document Group. 2025 ESC Guidelines for the management of myocarditis and pericarditis: Developed by the task force for the management of myocarditis and pericarditis of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2025;46:3952–4041. https://doi.org/10.1093/eurheartj/ehaf192</mixed-citation><mixed-citation xml:lang="en">Jeanette Schulz-Menger, Valentino Collini, Jan Gröschel, et al. The ESC Scientific Document Group. 2025 ESC Guidelines for the management of myocarditis and pericarditis: Developed by the task force for the management of myocarditis and pericarditis of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2025;46:3952–4041. https://doi.org/10.1093/eurheartj/ehaf192</mixed-citation></citation-alternatives></ref><ref id="cit120"><label>120</label><citation-alternatives><mixed-citation xml:lang="ru">Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet 2024; 363:717–727. https://doi.org/10.1016/s0140-6736(04)15648-1</mixed-citation><mixed-citation xml:lang="en">Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet 2024; 363:717–727. https://doi.org/10.1016/s0140-6736(04)15648-1</mixed-citation></citation-alternatives></ref><ref id="cit121"><label>121</label><citation-alternatives><mixed-citation xml:lang="ru">Galea N, Polizzi G, Gatti M et al. Cardiovascular magnetic resonance (CMR) in restrictive cardiomyopathies. Radiol Med 2020;125:1072– 1086. https://doi.org/10.1007/s11547-020-01287-8</mixed-citation><mixed-citation xml:lang="en">Galea N, Polizzi G, Gatti M et al. Cardiovascular magnetic resonance (CMR) in restrictive cardiomyopathies. Radiol Med 2020;125:1072– 1086. https://doi.org/10.1007/s11547-020-01287-8</mixed-citation></citation-alternatives></ref><ref id="cit122"><label>122</label><citation-alternatives><mixed-citation xml:lang="ru">Amaki M, Savino J, Ain DL et al. Diagnostic concordance of echocardiography and cardiac magnetic resonance-based tissue tracking for differentiating constrictive pericarditis from restrictive cardiomyopathy. Circ Cardiovasc Imaging 2024;7:819–827. https://doi.org/10.1161/CIRCIMAGING.114.002103</mixed-citation><mixed-citation xml:lang="en">Amaki M, Savino J, Ain DL et al. Diagnostic concordance of echocardiography and cardiac magnetic resonance-based tissue tracking for differentiating constrictive pericarditis from restrictive cardiomyopathy. Circ Cardiovasc Imaging 2024;7:819–827. https://doi.org/10.1161/CIRCIMAGING.114.002103</mixed-citation></citation-alternatives></ref><ref id="cit123"><label>123</label><citation-alternatives><mixed-citation xml:lang="ru">Vereckei A., Besenyi Z., Nagy V., et al. Cardiac Sarcoidosis: A Comprehensive Clinical Review. Rev Cardiovasc Med. 2024;25(2):37. https://doi.org/10.31083/j.rcm2502037</mixed-citation><mixed-citation xml:lang="en">Vereckei A., Besenyi Z., Nagy V., et al. Cardiac Sarcoidosis: A Comprehensive Clinical Review. Rev Cardiovasc Med. 2024;25(2):37. https://doi.org/10.31083/j.rcm2502037</mixed-citation></citation-alternatives></ref><ref id="cit124"><label>124</label><citation-alternatives><mixed-citation xml:lang="ru">Smedema J-P., Snoep G., van Kroonenburgh M.P.G., et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005;45(10):1683–1690. https://doi.org/10.1016/j.jacc.2005.01.047</mixed-citation><mixed-citation xml:lang="en">Smedema J-P., Snoep G., van Kroonenburgh M.P.G., et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005;45(10):1683–1690. https://doi.org/10.1016/j.jacc.2005.01.047</mixed-citation></citation-alternatives></ref><ref id="cit125"><label>125</label><citation-alternatives><mixed-citation xml:lang="ru">Birnie D.H., Sauer W.H., Bogun F., et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305–1323. https://doi.org/10.1016/j.hrthm.2014.03.04</mixed-citation><mixed-citation xml:lang="en">Birnie D.H., Sauer W.H., Bogun F., et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305–1323. https://doi.org/10.1016/j.hrthm.2014.03.04</mixed-citation></citation-alternatives></ref><ref id="cit126"><label>126</label><citation-alternatives><mixed-citation xml:lang="ru">Yoshinaga K., Miyagawa M., Kiso K., Ishida Y. Japanese Guidelines for Cardiac Sarcoidosis. Japanese Guidelines for Cardiac Sarcoidosis. Ann. Nucl. Cardiol. 2017;3(1):121–124. https://doi.org/10.17996/anc.17-000</mixed-citation><mixed-citation xml:lang="en">Yoshinaga K., Miyagawa M., Kiso K., Ishida Y. Japanese Guidelines for Cardiac Sarcoidosis. Japanese Guidelines for Cardiac Sarcoidosis. Ann. Nucl. Cardiol. 2017;3(1):121–124. https://doi.org/10.17996/anc.17-000</mixed-citation></citation-alternatives></ref><ref id="cit127"><label>127</label><citation-alternatives><mixed-citation xml:lang="ru">Sato K., Kawamatsu N., Yamamoto M., et al. Utility of Updated Japanese Circulation Society Guidelines to Diagnose Isolated Cardiac Sarcoidosis. J Am Hart Assoc. 2022;11(13):e025565. https://doi.org/10.1161/JAHA.122.025565</mixed-citation><mixed-citation xml:lang="en">Sato K., Kawamatsu N., Yamamoto M., et al. Utility of Updated Japanese Circulation Society Guidelines to Diagnose Isolated Cardiac Sarcoidosis. J Am Hart Assoc. 2022;11(13):e025565. https://doi.org/10.1161/JAHA.122.025565</mixed-citation></citation-alternatives></ref><ref id="cit128"><label>128</label><citation-alternatives><mixed-citation xml:lang="ru">Майрина С.В., Рыжкова Д.В., Митрофанова Л.Б., Рыжков А.В., Муртазалиева П.М., Моисеева О.М. Современные подходы к диагностике и лечению саркоидоза сердца: результаты когортного исследования. Российский кардиологический журнал. 2023;28(5):5301. https://doi.org/10.15829/1560-4071-2023-5301</mixed-citation><mixed-citation xml:lang="en">Mairina S.V., Ryzhkova D.V., Mitrofanova L.B., Ryzhkov A.V., Murtazalieva P.M., Moiseeva O.M. Modern approaches to the diagnosis and treatment of cardiac sarcoidosis: results of a cohort study. Russian Journal of Cardiology. 2023;28(5):5301. (In Russ.) https://doi.org/10.15829/1560-4071-2023-5301</mixed-citation></citation-alternatives></ref><ref id="cit129"><label>129</label><citation-alternatives><mixed-citation xml:lang="ru">Kafil TS, et al. Global practices in cardiac imaging for cardiac sarcoidosis: A survey study of international experts with Delphi consensus. JACC: Cardiovascular Imaging. 2025;18:679-692. https://doi.org/10.1016/j.jcmg.2025.02.010</mixed-citation><mixed-citation xml:lang="en">Kafil TS, et al. Global practices in cardiac imaging for cardiac sarcoidosis: A survey study of international experts with Delphi consensus. JACC: Cardiovascular Imaging. 2025;18:679-692. https://doi.org/10.1016/j.jcmg.2025.02.010</mixed-citation></citation-alternatives></ref><ref id="cit130"><label>130</label><citation-alternatives><mixed-citation xml:lang="ru">Delgado V, Ajmone Marsan N, De Waha S et al (2023) 2023 ESC guidelines for the management of endocarditis. Eur Heart J 44:3948–4042. https://doi.org/10.1093/eurheartj/ehad193</mixed-citation><mixed-citation xml:lang="en">Delgado V, Ajmone Marsan N, De Waha S et al (2023) 2023 ESC guidelines for the management of endocarditis. Eur Heart J 44:3948–4042. https://doi.org/10.1093/eurheartj/ehad193</mixed-citation></citation-alternatives></ref><ref id="cit131"><label>131</label><citation-alternatives><mixed-citation xml:lang="ru">Moons P, Bovijn L, Budts W, Belmans A, Gewillig M. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation. 2010;122:2264– 2272. https://doi.org/10.1161/circulationaha.110.946343</mixed-citation><mixed-citation xml:lang="en">Moons P, Bovijn L, Budts W, Belmans A, Gewillig M. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation. 2010;122:2264– 2272. https://doi.org/10.1161/circulationaha.110.946343</mixed-citation></citation-alternatives></ref><ref id="cit132"><label>132</label><citation-alternatives><mixed-citation xml:lang="ru">Powell AJ, Geva T. Blood flow measurement by magnetic resonance imaging in congenital heart disease. Pediatr Cardiol. 2000 JanFeb;21(1):47-58. PMID: 10672614. https://doi.org/10.1007/s002469910007</mixed-citation><mixed-citation xml:lang="en">Powell AJ, Geva T. Blood flow measurement by magnetic resonance imaging in congenital heart disease. Pediatr Cardiol. 2000 JanFeb;21(1):47-58. PMID: 10672614. https://doi.org/10.1007/s002469910007</mixed-citation></citation-alternatives></ref><ref id="cit133"><label>133</label><citation-alternatives><mixed-citation xml:lang="ru">Yamasaki Y, Kawanami S, Kamitani T, et al. Noninvasive quantification of left-to-right shunt by phase contrast magnetic resonance imaging in secundum atrial septal defect: the effects of breath holding and comparison with invasive oximetry. Int J Cardiovasc Imaging. 2018 Jun;34(6):931-937. Epub 2018 Jan 16. PMID: 29340831. https://doi.org/10.1007/s10554-018-1297-1</mixed-citation><mixed-citation xml:lang="en">Yamasaki Y, Kawanami S, Kamitani T, et al. Noninvasive quantification of left-to-right shunt by phase contrast magnetic resonance imaging in secundum atrial septal defect: the effects of breath holding and comparison with invasive oximetry. Int J Cardiovasc Imaging. 2018 Jun;34(6):931-937. Epub 2018 Jan 16. PMID: 29340831. https://doi.org/10.1007/s10554-018-1297-1</mixed-citation></citation-alternatives></ref><ref id="cit134"><label>134</label><citation-alternatives><mixed-citation xml:lang="ru">Tondi L, Figliozzi S, Boveri S, et al. Cardiovascular magnetic resonance semi-automated threshold-based post-processing of right ventricular volumes in repaired tetralogy of Fallot. Radiol Med. 2024 Dec;129(12):1830-1839. Epub 2024 Oct 30. PMID: 39476274. https://doi.org/10.1007/s11547-024-01908-6</mixed-citation><mixed-citation xml:lang="en">Tondi L, Figliozzi S, Boveri S, et al. Cardiovascular magnetic resonance semi-automated threshold-based post-processing of right ventricular volumes in repaired tetralogy of Fallot. Radiol Med. 2024 Dec;129(12):1830-1839. Epub 2024 Oct 30. PMID: 39476274. https://doi.org/10.1007/s11547-024-01908-6</mixed-citation></citation-alternatives></ref><ref id="cit135"><label>135</label><citation-alternatives><mixed-citation xml:lang="ru">Blalock SE, Banka P, Geva T, Powell AJ, et al. Interstudy variability in cardiac magnetic resonance imaging measurements of ventricular volume, mass, and ejection fraction in repaired tetralogy of Fallot: A prospective observational study. J Magn Reson Imaging . 2013 Oct;38(4):829-35. https://doi.org/10.1002/jmri.24050</mixed-citation><mixed-citation xml:lang="en">Blalock SE, Banka P, Geva T, Powell AJ, et al. Interstudy variability in cardiac magnetic resonance imaging measurements of ventricular volume, mass, and ejection fraction in repaired tetralogy of Fallot: A prospective observational study. J Magn Reson Imaging . 2013 Oct;38(4):829-35. https://doi.org/10.1002/jmri.24050</mixed-citation></citation-alternatives></ref><ref id="cit136"><label>136</label><citation-alternatives><mixed-citation xml:lang="ru">Budts W, Miller O, Babu-Narayan SV, et al. Imaging the adult with simple shunt lesions: position paper from the EACVI and the ESC WG on ACHD. Endorsed by AEPC (Association for European Paediatric and Congenital Cardiology). Eur Heart J Cardiovasc Imaging. 2021 May 10;22(6):e58-e70. PMID: 33338215. https://doi.org/10.1093/ehjci/jeaa314</mixed-citation><mixed-citation xml:lang="en">Budts W, Miller O, Babu-Narayan SV, et al. Imaging the adult with simple shunt lesions: position paper from the EACVI and the ESC WG on ACHD. Endorsed by AEPC (Association for European Paediatric and Congenital Cardiology). Eur Heart J Cardiovasc Imaging. 2021 May 10;22(6):e58-e70. PMID: 33338215. https://doi.org/10.1093/ehjci/jeaa314</mixed-citation></citation-alternatives></ref><ref id="cit137"><label>137</label><citation-alternatives><mixed-citation xml:lang="ru">Devos DG, Kilner PJ. Calculations of cardiovascular shunts and regurgitation using magnetic resonance ventricular volume and aortic and pulmonary flow measurements. Eur Radiol 2010;20:410– 21. https://doi.org/10.1007/s00330-009-1568-2</mixed-citation><mixed-citation xml:lang="en">Devos DG, Kilner PJ. Calculations of cardiovascular shunts and regurgitation using magnetic resonance ventricular volume and aortic and pulmonary flow measurements. Eur Radiol 2010;20:410– 21. https://doi.org/10.1007/s00330-009-1568-2</mixed-citation></citation-alternatives></ref><ref id="cit138"><label>138</label><citation-alternatives><mixed-citation xml:lang="ru">Kato A, Riesenkampff E, Yim D, et al. Pediatric Fontan patients are at risk for myocardial fibrotic remodeling and dysfunction. Int J Cardiol. 2017;240:172–177. https://doi.org/10.1016/j.ijcard.2017.04.073</mixed-citation><mixed-citation xml:lang="en">Kato A, Riesenkampff E, Yim D, et al. Pediatric Fontan patients are at risk for myocardial fibrotic remodeling and dysfunction. Int J Cardiol. 2017;240:172–177. https://doi.org/10.1016/j.ijcard.2017.04.073</mixed-citation></citation-alternatives></ref><ref id="cit139"><label>139</label><citation-alternatives><mixed-citation xml:lang="ru">Wald RM, Haber I, Wald R, et al. Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot. Circulation. 2009;119:1370–7. https://doi.org/10.1161/circulationaha.108.816546</mixed-citation><mixed-citation xml:lang="en">Wald RM, Haber I, Wald R, et al. Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot. Circulation. 2009;119:1370–7. https://doi.org/10.1161/circulationaha.108.816546</mixed-citation></citation-alternatives></ref><ref id="cit140"><label>140</label><citation-alternatives><mixed-citation xml:lang="ru">Babu-Narayan SV, Kilner PJ, Li W, et al. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation. 2006;113:405–13. https://doi.org/10.1161/circulationaha.105.548727</mixed-citation><mixed-citation xml:lang="en">Babu-Narayan SV, Kilner PJ, Li W, et al. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation. 2006;113:405–13. https://doi.org/10.1161/circulationaha.105.548727</mixed-citation></citation-alternatives></ref><ref id="cit141"><label>141</label><citation-alternatives><mixed-citation xml:lang="ru">Babu-Narayan SV, Goktekin O, Moon JC, et al. Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Circulation. 2005;111:2091–8. https://doi.org/10.1161/01.cir.0000162463.61626.3b</mixed-citation><mixed-citation xml:lang="en">Babu-Narayan SV, Goktekin O, Moon JC, et al. Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Circulation. 2005;111:2091–8. https://doi.org/10.1161/01.cir.0000162463.61626.3b</mixed-citation></citation-alternatives></ref><ref id="cit142"><label>142</label><citation-alternatives><mixed-citation xml:lang="ru">Giardini A, Lovato L, Donti A, et al. Relation between right ventricular structural alterations and markers of adverse clinical outcome in adults with systemic right ventricle and either congenital complete (after senning operation) or congenitally corrected transposition of the great arteries. Am J Cardiol. 2006;98:1277–82. https://doi.org/10.1016/j.amjcard.2006.05.062</mixed-citation><mixed-citation xml:lang="en">Giardini A, Lovato L, Donti A, et al. Relation between right ventricular structural alterations and markers of adverse clinical outcome in adults with systemic right ventricle and either congenital complete (after senning operation) or congenitally corrected transposition of the great arteries. Am J Cardiol. 2006;98:1277–82. https://doi.org/10.1016/j.amjcard.2006.05.062</mixed-citation></citation-alternatives></ref><ref id="cit143"><label>143</label><citation-alternatives><mixed-citation xml:lang="ru">Lancellotti P, Pibarot P, Chambers J, et al. Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper. Eur Heart J Cardiovasc Imaging 2022;23:e171–232. https://doi.org/10.1093/ehjci/jeab253</mixed-citation><mixed-citation xml:lang="en">Lancellotti P, Pibarot P, Chambers J, et al. Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper. Eur Heart J Cardiovasc Imaging 2022;23:e171–232. https://doi.org/10.1093/ehjci/jeab253</mixed-citation></citation-alternatives></ref><ref id="cit144"><label>144</label><citation-alternatives><mixed-citation xml:lang="ru">Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2017;30:303–71. https://doi.org/10.1016/j.echo.2017.01.007</mixed-citation><mixed-citation xml:lang="en">Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2017;30:303–71. https://doi.org/10.1016/j.echo.2017.01.007</mixed-citation></citation-alternatives></ref><ref id="cit145"><label>145</label><citation-alternatives><mixed-citation xml:lang="ru">Lee JKT, Franzone A, Lanz J, et al. Early Detection of Subclinical Myocardial Damage in Chronic Aortic Regurgitation and Strategies for Timely Treatment of Asymptomatic Patients. Circulation. 2018 Jan 9;137(2):184-196. PMID: 29311349. https://doi.org/10.1161/CIRCULATIONAHA.117.029858</mixed-citation><mixed-citation xml:lang="en">Lee JKT, Franzone A, Lanz J, et al. Early Detection of Subclinical Myocardial Damage in Chronic Aortic Regurgitation and Strategies for Timely Treatment of Asymptomatic Patients. Circulation. 2018 Jan 9;137(2):184-196. PMID: 29311349. https://doi.org/10.1161/CIRCULATIONAHA.117.029858</mixed-citation></citation-alternatives></ref><ref id="cit146"><label>146</label><citation-alternatives><mixed-citation xml:lang="ru">Evangelista A, Sitges M, Jondeau G, et al. Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases. Eur Heart J Cardiovasc Imaging. 2023 Apr 24;24(5):e65-e85. https://doi.org/10.1093/ehjci/jead024. Erratum in: Eur Heart J Cardiovasc Imaging. 2023 Jul 24;24(8):e208. PMID: 36881779. https://doi.org/10.1093/ehjci/jead122</mixed-citation><mixed-citation xml:lang="en">Evangelista A, Sitges M, Jondeau G, et al. Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases. Eur Heart J Cardiovasc Imaging. 2023 Apr 24;24(5):e65-e85. https://doi.org/10.1093/ehjci/jead024. Erratum in: Eur Heart J Cardiovasc Imaging. 2023 Jul 24;24(8):e208. PMID: 36881779. https://doi.org/10.1093/ehjci/jead122</mixed-citation></citation-alternatives></ref><ref id="cit147"><label>147</label><citation-alternatives><mixed-citation xml:lang="ru">Reindl M, Lechner I, Holzknecht M, et al. Cardiac Magnetic Resonance Imaging Versus Computed Tomography to Guide Transcatheter Aortic Valve Replacement: A Randomized, OpenLabel, Noninferiority Trial. Circulation. 2023 Oct 17;148(16):1220- 1230. Epub 2023 Aug 27. PMID: 37634187. https://doi.org/10.1161/CIRCULATIONAHA.123.066498</mixed-citation><mixed-citation xml:lang="en">Reindl M, Lechner I, Holzknecht M, et al. Cardiac Magnetic Resonance Imaging Versus Computed Tomography to Guide Transcatheter Aortic Valve Replacement: A Randomized, OpenLabel, Noninferiority Trial. Circulation. 2023 Oct 17;148(16):1220- 1230. Epub 2023 Aug 27. PMID: 37634187. https://doi.org/10.1161/CIRCULATIONAHA.123.066498</mixed-citation></citation-alternatives></ref><ref id="cit148"><label>148</label><citation-alternatives><mixed-citation xml:lang="ru">Naoum C, Blanke P, Cavalcante JL, Leipsic J. Cardiac Computed Tomography and Magnetic Resonance Imaging in the Evaluation of Mitral and Tricuspid Valve Disease: Implications for Transcatheter Interventions. Circ Cardiovasc Imaging. 2017 Mar;10(3):e005331. PMID: 28292860. https://doi.org/10.1161/CIRCIMAGING.116.005331</mixed-citation><mixed-citation xml:lang="en">Naoum C, Blanke P, Cavalcante JL, Leipsic J. Cardiac Computed Tomography and Magnetic Resonance Imaging in the Evaluation of Mitral and Tricuspid Valve Disease: Implications for Transcatheter Interventions. Circ Cardiovasc Imaging. 2017 Mar;10(3):e005331. PMID: 28292860. https://doi.org/10.1161/CIRCIMAGING.116.005331</mixed-citation></citation-alternatives></ref><ref id="cit149"><label>149</label><citation-alternatives><mixed-citation xml:lang="ru">Lee JKT, Franzone A, Lanz J, et al. Early Detection of Subclinical Myocardial Damage in Chronic Aortic Regurgitation and Strategies for Timely Treatment of Asymptomatic Patients. Circulation. 2018 Jan 9;137(2):184-196. PMID: 29311349. https://doi.org/10.1161/CIRCULATIONAHA.117.029858</mixed-citation><mixed-citation xml:lang="en">Lee JKT, Franzone A, Lanz J, et al. Early Detection of Subclinical Myocardial Damage in Chronic Aortic Regurgitation and Strategies for Timely Treatment of Asymptomatic Patients. Circulation. 2018 Jan 9;137(2):184-196. PMID: 29311349. https://doi.org/10.1161/CIRCULATIONAHA.117.029858</mixed-citation></citation-alternatives></ref><ref id="cit150"><label>150</label><citation-alternatives><mixed-citation xml:lang="ru">Richmond C. Wallace William Brigden. BMJ. 2008;336(7657):1382. https://doi.org/10.1136/bmj.a293</mixed-citation><mixed-citation xml:lang="en">Richmond C. Wallace William Brigden. BMJ. 2008;336(7657):1382. https://doi.org/10.1136/bmj.a293</mixed-citation></citation-alternatives></ref><ref id="cit151"><label>151</label><citation-alternatives><mixed-citation xml:lang="ru">Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44(37):3503-626. https://doi.org/10.1093/eurheartj/ehad194</mixed-citation><mixed-citation xml:lang="en">Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44(37):3503-626. https://doi.org/10.1093/eurheartj/ehad194</mixed-citation></citation-alternatives></ref><ref id="cit152"><label>152</label><citation-alternatives><mixed-citation xml:lang="ru">Ommen S.R., Ho C.Y., Asif I.M. et al. 2024 AHA/ACC/AMSSM/ HRS/PACES/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association/ American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2024;83:23:2324-2405. https://doi.org/10.1016/j.jacc.2024.02.014</mixed-citation><mixed-citation xml:lang="en">Ommen S.R., Ho C.Y., Asif I.M. et al. 2024 AHA/ACC/AMSSM/ HRS/PACES/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association/ American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2024;83:23:2324-2405. https://doi.org/10.1016/j.jacc.2024.02.014</mixed-citation></citation-alternatives></ref><ref id="cit153"><label>153</label><citation-alternatives><mixed-citation xml:lang="ru">Weng Z, Yao J, Chan RH, et al. Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging 2016;9:1392-02. https://doi.org/10.1016/j.jcmg.2016.02.031</mixed-citation><mixed-citation xml:lang="en">Weng Z, Yao J, Chan RH, et al. Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging 2016;9:1392-02. https://doi.org/10.1016/j.jcmg.2016.02.031</mixed-citation></citation-alternatives></ref><ref id="cit154"><label>154</label><citation-alternatives><mixed-citation xml:lang="ru">Omar Abdelfattah, Xander Jacquemyn, Wissam Khalife, et al. Revisiting Late Gadolinium Enhancement Cut off as a Risk Marker in Hypertrophic Cardiomyopathy. Journal of Cardiac Failure Volume. 2024 September 30;2:S12-S13. https://doi.org/10.1016/j.cardfail.2024.08.025</mixed-citation><mixed-citation xml:lang="en">Omar Abdelfattah, Xander Jacquemyn, Wissam Khalife, et al. Revisiting Late Gadolinium Enhancement Cut off as a Risk Marker in Hypertrophic Cardiomyopathy. Journal of Cardiac Failure Volume. 2024 September 30;2:S12-S13. https://doi.org/10.1016/j.cardfail.2024.08.025</mixed-citation></citation-alternatives></ref><ref id="cit155"><label>155</label><citation-alternatives><mixed-citation xml:lang="ru">Srekar N Ravi, Michael O'Shea, Omar Baqal, et al. The incremental role of late gadolinium enhancement in risk stratifying high risk patients with hypertrophic cardiomyopathy. Multicenter Study Am Heart J. 2025 Nov:289:28-37. https://doi.org/10.1016/j.ahj.2025.04.030</mixed-citation><mixed-citation xml:lang="en">Srekar N Ravi, Michael O'Shea, Omar Baqal, et al. The incremental role of late gadolinium enhancement in risk stratifying high risk patients with hypertrophic cardiomyopathy. Multicenter Study Am Heart J. 2025 Nov:289:28-37. https://doi.org/10.1016/j.ahj.2025.04.030</mixed-citation></citation-alternatives></ref><ref id="cit156"><label>156</label><citation-alternatives><mixed-citation xml:lang="ru">Feng XY, He WF, Zhang TY, et. Association between late gadolinial. um enhancement and outcome in dilated cardiomyopathy: A meta-analysis. World J Radiol 2023;15(11): 324-337. https://doi.org/10.4329/wjr.v15.i11.324</mixed-citation><mixed-citation xml:lang="en">Feng XY, He WF, Zhang TY, et. Association between late gadolinial. um enhancement and outcome in dilated cardiomyopathy: A meta-analysis. World J Radiol 2023;15(11): 324-337. https://doi.org/10.4329/wjr.v15.i11.324</mixed-citation></citation-alternatives></ref><ref id="cit157"><label>157</label><citation-alternatives><mixed-citation xml:lang="ru">Forouzannia SA, Rafiei Alavi SR, Forouzannia SM, et al. Prognostic value of CMR parametric mapping in cardiac amyloidosis: an updated systematic review and meta-analysis. Open Heart 2025;12:e003551. https://doi.org/10.1136/openhrt-2025-003551</mixed-citation><mixed-citation xml:lang="en">Forouzannia SA, Rafiei Alavi SR, Forouzannia SM, et al. Prognostic value of CMR parametric mapping in cardiac amyloidosis: an updated systematic review and meta-analysis. Open Heart 2025;12:e003551. https://doi.org/10.1136/openhrt-2025-003551</mixed-citation></citation-alternatives></ref><ref id="cit158"><label>158</label><citation-alternatives><mixed-citation xml:lang="ru">Awais Sheikh, Anouk Achten, Alberto Aimo, et al. Myocardial Amyloid Burden in Transthyretin Amyloidosis. JACC 2025;87(5):505-518. https://doi.org/10.1016/j.jacc.2025.10.054</mixed-citation><mixed-citation xml:lang="en">Awais Sheikh, Anouk Achten, Alberto Aimo, et al. Myocardial Amyloid Burden in Transthyretin Amyloidosis. JACC 2025;87(5):505-518. https://doi.org/10.1016/j.jacc.2025.10.054</mixed-citation></citation-alternatives></ref><ref id="cit159"><label>159</label><citation-alternatives><mixed-citation xml:lang="ru">Topriceanu CC, Al-Farih M, Joy G, Chan F, Webber M, et al. The Cardiovascular Magnetic Resonance Phenotype of Lamin Heart Disease. JACC Cardiovasc Imaging. 2025 Jun;18(6):644-660. https://doi.org/10.1016/j.jcmg.2025.01.004</mixed-citation><mixed-citation xml:lang="en">Topriceanu CC, Al-Farih M, Joy G, Chan F, Webber M, et al. The Cardiovascular Magnetic Resonance Phenotype of Lamin Heart Disease. JACC Cardiovasc Imaging. 2025 Jun;18(6):644-660. https://doi.org/10.1016/j.jcmg.2025.01.004</mixed-citation></citation-alternatives></ref><ref id="cit160"><label>160</label><citation-alternatives><mixed-citation xml:lang="ru">Zareba KM, Hershberger RE. Early Phenotype Identification: The Key to Taming Genetic Cardiomyopathies. JACC Cardiovasc Imaging. 2025 Jun;18(6):661-663. https://doi.org/10.1016/j.jcmg.2025.02.008</mixed-citation><mixed-citation xml:lang="en">Zareba KM, Hershberger RE. Early Phenotype Identification: The Key to Taming Genetic Cardiomyopathies. JACC Cardiovasc Imaging. 2025 Jun;18(6):661-663. https://doi.org/10.1016/j.jcmg.2025.02.008</mixed-citation></citation-alternatives></ref><ref id="cit161"><label>161</label><citation-alternatives><mixed-citation xml:lang="ru">Бокерия Л.А., Шляхто Е.В., Габрусенко С.А., и соавт. Гипертрофическая кардиомиопатия. Клинические рекомендации 2025. Российский кардиологический журнал. 2025;30(5):6387. EDN BUUCJT. https://doi.org/10.15829/1560-4071-2025-6387 [Bokeria l.A., Shlyakhto E.V., Gabrusenko S.A., et al. 2025 Clinical practice guidelines for Hypertrophic cardiomyopathy. Russian Journal of Cardiology. 2025;30(5):6387. (In Russ.) https://doi.org/10.15829/1560-4071-2025-6387]</mixed-citation><mixed-citation xml:lang="en">Bokeria l.A., Shlyakhto E.V., Gabrusenko S.A., et al. 2025 Clinical practice guidelines for Hypertrophic cardiomyopathy. Russian Journal of Cardiology. 2025;30(5):6387. (In Russ.) https://doi.org/10.15829/1560-4071-2025-6387</mixed-citation></citation-alternatives></ref><ref id="cit162"><label>162</label><citation-alternatives><mixed-citation xml:lang="ru">Шаяхметова С.В., Синицын В.Е., Афанасьев А.В. Магнитнорезонансная томография сердца при гипертрофической кардиомиопатии: диагностические возможности, применение в клинической практике, прогностическая значимость. Российский кардиологический журнал. 2019;(12):131-136. https://doi.org/10.15829/1560-4071-2019-12-131-136</mixed-citation><mixed-citation xml:lang="en">Shayakhmetova S.V., Sinitsyn V.E., Afanasyev A.V. Cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: diagnostic and prognostic value. Russian Journal of Cardiology. 2019;(12):131-136. (In Russ.) https://doi.org/10.15829/1560-4071-2019-12-131-136</mixed-citation></citation-alternatives></ref><ref id="cit163"><label>163</label><citation-alternatives><mixed-citation xml:lang="ru">Huurman R, Van Der Velde N, Schinkel AFL, et al. Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance. Eur Hear Journal Cardiovasc Imaging. 2022;23(9):1144-54. https://doi.org/10.1093/EHJCI/JEAC099</mixed-citation><mixed-citation xml:lang="en">Huurman R, Van Der Velde N, Schinkel AFL, et al. Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance. Eur Hear Journal Cardiovasc Imaging. 2022;23(9):1144-54. https://doi.org/10.1093/EHJCI/JEAC099</mixed-citation></citation-alternatives></ref><ref id="cit164"><label>164</label><citation-alternatives><mixed-citation xml:lang="ru">Bois JP, Geske JB, Foley TA, et al. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography. Am J Cardiol. 2017;119(4):643-50. https://doi.org/10.1016/J.AMJCARD.2016.11.010</mixed-citation><mixed-citation xml:lang="en">Bois JP, Geske JB, Foley TA, et al. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography. Am J Cardiol. 2017;119(4):643-50. https://doi.org/10.1016/J.AMJCARD.2016.11.010</mixed-citation></citation-alternatives></ref><ref id="cit165"><label>165</label><citation-alternatives><mixed-citation xml:lang="ru">Ameya Jagdish Baxi, Carlos S. Restrepo, et al. Hypertrophic Cardiomyopathy from A to Z: Genetics, Pathophysiology, Imaging, and Management. RadioGraphics 2016;36:335–354. PMID: 26963450. https://doi.org/10.1148/rg.2016150137</mixed-citation><mixed-citation xml:lang="en">Ameya Jagdish Baxi, Carlos S. Restrepo, et al. Hypertrophic Cardiomyopathy from A to Z: Genetics, Pathophysiology, Imaging, and Management. RadioGraphics 2016;36:335–354. PMID: 26963450. https://doi.org/10.1148/rg.2016150137</mixed-citation></citation-alternatives></ref><ref id="cit166"><label>166</label><citation-alternatives><mixed-citation xml:lang="ru">Малов А.А., Джорджикия Р.К., Абушаев А.И. Диагностические возможности магнитнорезонансной томографии сердца в дифференциальной диагностике фенотипических форм гипертрофической кардиомиопатии. Лучевая диагностика и терапия. 2020;11(4):44–51. https://doi.org/10.22328/2079-5343-2020-11-4-44-51</mixed-citation><mixed-citation xml:lang="en">Malov A.A., Dzhordzhikiya R.K., Abushayev A.I. Diagnostic opportunities of magnetic resonant imagingmri of heart in differential diagnosis of phenotypical forms of hypertrophic cardiomyopathy. Diagnostic radiology and radiotherapy. 2020;11(4):44-51. (In Russ.) https://doi.org/10.22328/2079-5343-2020-11-4-44-51</mixed-citation></citation-alternatives></ref><ref id="cit167"><label>167</label><citation-alternatives><mixed-citation xml:lang="ru">Syed IS, Glockner JF, Feng DL, et al. Role of Cardiac Magnetic Resonance Imaging in the Detection of Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2010;3(2):155-64. https://doi.org/10.1016/j.jcmg.2009.09.023</mixed-citation><mixed-citation xml:lang="en">Syed IS, Glockner JF, Feng DL, et al. Role of Cardiac Magnetic Resonance Imaging in the Detection of Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2010;3(2):155-64. https://doi.org/10.1016/j.jcmg.2009.09.023</mixed-citation></citation-alternatives></ref><ref id="cit168"><label>168</label><citation-alternatives><mixed-citation xml:lang="ru">Vogelsberg H, Mahrholdt H, Deluigi CC, et al. Cardiovascular Magnetic Resonance in Clinically Suspected Cardiac Amyloidosis. Noninvasive Imaging Compared to Endomyocardial Biopsy. J Am Coll Cardiol. 2008;51(10):1022-30. https://doi.org/10.1016/j.jacc.2007.10.049</mixed-citation><mixed-citation xml:lang="en">Vogelsberg H, Mahrholdt H, Deluigi CC, et al. Cardiovascular Magnetic Resonance in Clinically Suspected Cardiac Amyloidosis. Noninvasive Imaging Compared to Endomyocardial Biopsy. J Am Coll Cardiol. 2008;51(10):1022-30. https://doi.org/10.1016/j.jacc.2007.10.049</mixed-citation></citation-alternatives></ref><ref id="cit169"><label>169</label><citation-alternatives><mixed-citation xml:lang="ru">Жиров И.В., Насонова С.Н., Моисеева О.М., и соавт. Амилоидоз сердца: консенсус Евразийской ассоциации кардиологов (ЕАК). Евразийский кардиологический журнал. 2025;(4):6-39. https://doi.org/10.38109/2225-1685-2025-4-6-39</mixed-citation><mixed-citation xml:lang="en">Zhirov I.V., Nasonova S.N., Moiseeva O.M., Rekhtina I.G., Suponeva N.A., Ansheles А.A., Barbarash O.L., Galyavich A.S., Duplyakov D.V., Zateishchikov D.A., Saidova M.A., Tchaikovskaya O.Ya., Shariya M.A., Tereshchenko S.N. Cardiac amyloidosis: consensus of the Eurasian Association of Cardiologists (EAC). Eurasian heart journal. 2025;(4):6-39. (In Russ.) https://doi.org/10.38109/2225-1685-2025-4-6-39</mixed-citation></citation-alternatives></ref><ref id="cit170"><label>170</label><citation-alternatives><mixed-citation xml:lang="ru">Дземешкевич С.Л., Грамович В.В., Синицин В.Е., Стукалова О.В., и соавт. Гипертрофическая кардиомиопатия в стадии декомпенсации кровообращения: трансплантация или обратное ремоделирование. Клиническая и экспериментальная хирургия. Журнал имени академика Б.В. Петровского. 2023;11(2):101-100. https://doi.org/10.33029/2308-1198-2023-11-2-101-110</mixed-citation><mixed-citation xml:lang="en">Dzemeshkevich S.L., Gramovich V.V., Sinitsyn V.E., Stukalova O.V., et al. Hypertrophic cardiomyopathy at the circulatory decompensation stage: transplantation or reverse remodeling. Clinical and Experimental Surgery. Petrovsky Journal. 2023;11(2):101-10. (In Russ.) https://doi.org/10.33029/2308-1198-2023-11-2-101-110</mixed-citation></citation-alternatives></ref><ref id="cit171"><label>171</label><citation-alternatives><mixed-citation xml:lang="ru">Дземешкевич С.Л., Мотрева А.П., Корж Д.А., и соавт. Гипертрофическая кардиомиопатия: септальная миоэктомия и алкогольная аблация должны быть персонализированы Клиническая и экспериментальная хирургия. Журнал имени академика Б.В. Петровского. 2025;13(1):105-111. https://doi.org/10.33029/2308-1198-2025-13-1-105-111</mixed-citation><mixed-citation xml:lang="en">Dzemeshkevich S.L, Motreva A.P., Korzh A.D., et al. Hypertrophic cardiomyopathy: septal myectomy and alcohol ablation should be personalized. Clinical and Experimental Surgery. Petrovsky Journal. 2025;13(1):105-11. (In Russ.) https://doi.org/10.33029/2308-1198-2025-13-1-105-111</mixed-citation></citation-alternatives></ref><ref id="cit172"><label>172</label><citation-alternatives><mixed-citation xml:lang="ru">Дземешкевич С.Л., Мотрева А.П., Мартьянова Ю.Б., и соавт. Сочетанные операции при гипертрофической кардиомиопатии. Клиническая и экспериментальная хирургия. Журнал имени академика Б.В. Петровского. 2022;10(3):59-63. https://doi.org/10.33029/2308-1198-2022-10-3-59-63</mixed-citation><mixed-citation xml:lang="en">Dzemeshkevich S.L., Motreva A.P., Мартьянова Yu.B., Kalmykova O.V., Sadekova M.A., Zaklyazminskaya E.V. Combined operations for hypertrophic cardiomyopathy. Clinical and Experimental Surgery. Petrovsky Journal. 2022;10(3):59-63. (In Russ.) https://doi.org/10.33029/2308-1198-2022-10-3-59-63</mixed-citation></citation-alternatives></ref><ref id="cit173"><label>173</label><citation-alternatives><mixed-citation xml:lang="ru">Liu J, Zhao S, Yu S, et al. Patterns of Replacement Fibrosis in Hypertrophic Cardiomyopathy. Radiology. 2022;302(2):298-306. https://doi.org/10.1148/radiol.2021210914</mixed-citation><mixed-citation xml:lang="en">Liu J, Zhao S, Yu S, et al. Patterns of Replacement Fibrosis in Hypertrophic Cardiomyopathy. Radiology. 2022;302(2):298-306. https://doi.org/10.1148/radiol.2021210914</mixed-citation></citation-alternatives></ref><ref id="cit174"><label>174</label><citation-alternatives><mixed-citation xml:lang="ru">Chan RH, Maron BJ, Olivotto I, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014;130(6):484-95. https://doi.org/10.1161/CIRCULATIONAHA.113.007094.</mixed-citation><mixed-citation xml:lang="en">Chan RH, Maron BJ, Olivotto I, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014;130(6):484-95. https://doi.org/10.1161/CIRCULATIONAHA.113.007094.</mixed-citation></citation-alternatives></ref><ref id="cit175"><label>175</label><citation-alternatives><mixed-citation xml:lang="ru">Vullaganti S, Levine J, Raiker N, et al. Fibrosis in Hypertrophic Cardiomyopathy Patients With and Without Sarcomere Gene Mutations. Hear Lung Circ. 2021;30(10):1496-501. https://doi.org/10.1016/j.hlc.2021.04.008</mixed-citation><mixed-citation xml:lang="en">Vullaganti S, Levine J, Raiker N, et al. Fibrosis in Hypertrophic Cardiomyopathy Patients With and Without Sarcomere Gene Mutations. Hear Lung Circ. 2021;30(10):1496-501. https://doi.org/10.1016/j.hlc.2021.04.008</mixed-citation></citation-alternatives></ref><ref id="cit176"><label>176</label><citation-alternatives><mixed-citation xml:lang="ru">Garcia-Pavia P, Rapezzi C, Adler Y, et al. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur J Heart Fail. 2021;23(4):512-526. Epub 2021 Apr 7. PMID: 33826207. https://doi.org/10.1002/ejhf.2140</mixed-citation><mixed-citation xml:lang="en">Garcia-Pavia P, Rapezzi C, Adler Y, et al. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur J Heart Fail. 2021;23(4):512-526. Epub 2021 Apr 7. PMID: 33826207. https://doi.org/10.1002/ejhf.2140</mixed-citation></citation-alternatives></ref><ref id="cit177"><label>177</label><citation-alternatives><mixed-citation xml:lang="ru">Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016;133(24):2404- 12. https://doi.org/10.1161/CIRCULATIONAHA.116.021612</mixed-citation><mixed-citation xml:lang="en">Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016;133(24):2404- 12. https://doi.org/10.1161/CIRCULATIONAHA.116.021612</mixed-citation></citation-alternatives></ref><ref id="cit178"><label>178</label><citation-alternatives><mixed-citation xml:lang="ru">Maggialetti N., Torrente A., Lorusso G., et al. Role of Cardiovascular Magnetic Resonance in Cardiac Amyloidosis: A Narrative Review. J Pers Med. 2024;14(4):407. https://doi.org/10.3390/jpm14040407</mixed-citation><mixed-citation xml:lang="en">Maggialetti N., Torrente A., Lorusso G., et al. Role of Cardiovascular Magnetic Resonance in Cardiac Amyloidosis: A Narrative Review. J Pers Med. 2024;14(4):407. https://doi.org/10.3390/jpm14040407</mixed-citation></citation-alternatives></ref><ref id="cit179"><label>179</label><citation-alternatives><mixed-citation xml:lang="ru">Fontana M, Pica S, Reant P, et al. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis. Circulation. 2015;20;132(16):1570-9. https://doi.org/10.1161/CIRCULATIONAHA.115.016567</mixed-citation><mixed-citation xml:lang="en">Fontana M, Pica S, Reant P, et al. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis. Circulation. 2015;20;132(16):1570-9. https://doi.org/10.1161/CIRCULATIONAHA.115.016567</mixed-citation></citation-alternatives></ref><ref id="cit180"><label>180</label><citation-alternatives><mixed-citation xml:lang="ru">Martinez-Naharro A, Patel R, Kotecha T, et al. Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment. Eur Heart J. 2022;43(45):4722-4735. https://doi.org/10.1093/eurheartj/ehac363</mixed-citation><mixed-citation xml:lang="en">Martinez-Naharro A, Patel R, Kotecha T, et al. Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment. Eur Heart J. 2022;43(45):4722-4735. https://doi.org/10.1093/eurheartj/ehac363</mixed-citation></citation-alternatives></ref><ref id="cit181"><label>181</label><citation-alternatives><mixed-citation xml:lang="ru">Jason N Dungu, Oswaldo Valencia, Jennifer H Pinney, et al. CMRbased differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging. 2014;7(2):133-42. https://doi.org/10.1016/j.jcmg.2013.08.015</mixed-citation><mixed-citation xml:lang="en">Jason N Dungu, Oswaldo Valencia, Jennifer H Pinney, et al. CMRbased differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging. 2014;7(2):133-42. https://doi.org/10.1016/j.jcmg.2013.08.015</mixed-citation></citation-alternatives></ref><ref id="cit182"><label>182</label><citation-alternatives><mixed-citation xml:lang="ru">Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013;6(4):488-497. https://doi.org/10.1016/j.jcmg.2012.11.013 114</mixed-citation><mixed-citation xml:lang="en">Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013;6(4):488-497. https://doi.org/10.1016/j.jcmg.2012.11.013 114</mixed-citation></citation-alternatives></ref><ref id="cit183"><label>183</label><citation-alternatives><mixed-citation xml:lang="ru">Lavall D, Vosshage NH, Geßner R, et al. Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy. Clin Res Cardiol. 2023;112(3):334-342. https://doi.org/10.1007/s00392-022-02005-2</mixed-citation><mixed-citation xml:lang="en">Lavall D, Vosshage NH, Geßner R, et al. Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy. Clin Res Cardiol. 2023;112(3):334-342. https://doi.org/10.1007/s00392-022-02005-2</mixed-citation></citation-alternatives></ref><ref id="cit184"><label>184</label><citation-alternatives><mixed-citation xml:lang="ru">Jason N Dungu, Oswaldo Valencia, Jennifer H Pinney, et al. CMRbased differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging. 2014;7(2):133-42. https://doi.org/10.1016/j.jcmg.2013.08.015</mixed-citation><mixed-citation xml:lang="en">Jason N Dungu, Oswaldo Valencia, Jennifer H Pinney, et al. CMRbased differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging. 2014;7(2):133-42. https://doi.org/10.1016/j.jcmg.2013.08.015</mixed-citation></citation-alternatives></ref><ref id="cit185"><label>185</label><citation-alternatives><mixed-citation xml:lang="ru">Бондарева А.А., Балыш Е.М., Статкевич Т.В., и соавт. Stepby-step диагностика амилоидоза сердца: от подозрения до верификации диагноза. Неотложная кардиология и кардиоваскулярные риски, 2024;8(2):2328–2336. https://doi.org/10.51922/2616-633X.2024.8.2.2328</mixed-citation><mixed-citation xml:lang="en">Bondareva A.A., Balysh E.M., Statkevich T.V., et al. Step-by-step diagnosis of cardiac amyloidosis: from suspicion to verification. Neotlozhnaya kardiologiya i kardiovaskulyarnye riski [Emergency cardiology and cardiovascular risks]. 2024;8(2):2328–2336. (In Russ.) https://doi.org/10.51922/2616-633X.2024.8.2.2328</mixed-citation></citation-alternatives></ref><ref id="cit186"><label>186</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X, Zhai N, Wang X, et al. Cardiovascular magnetic resonance findings in Danon disease: a case series of a family. Front. Cardiovasc. Med. 2023;10:1159576. https://doi.org/10.3389/fcvm.2023.1159576</mixed-citation><mixed-citation xml:lang="en">Liu X, Zhai N, Wang X, et al. Cardiovascular magnetic resonance findings in Danon disease: a case series of a family. Front. Cardiovasc. Med. 2023;10:1159576. https://doi.org/10.3389/fcvm.2023.1159576</mixed-citation></citation-alternatives></ref><ref id="cit187"><label>187</label><citation-alternatives><mixed-citation xml:lang="ru">Мясников Р.П., Нефедова Д.А., Кузина Н.Н., и соавт. Болезнь Данона у женщин: современный взгляд на проблему: серия клинических случаев. Российский кардиологический журнал. 2024;29(10S):6142. EDN: MDUURV. https://doi.org/10.15829/1560-4071-2024-6142</mixed-citation><mixed-citation xml:lang="en">Myasnikov R.P., Nefedova D.A., Kuzina N.N., et al. Danon disease in women: a modern view of the problem: a case series. Russian Journal of Cardiology. 2024;29(10S):6142. (In Russ.) https://doi.org/10.15829/1560-4071-2024-6142</mixed-citation></citation-alternatives></ref><ref id="cit188"><label>188</label><citation-alternatives><mixed-citation xml:lang="ru">Hagège A, Réant P, Habib G, Damy T, et al. Fabry disease in cardiology practice: literature review and expert point of view. Arch Cardiovasc Dis 2019;112:278–87. https://doi.org/10.1016/j.acvd.2019.01.002</mixed-citation><mixed-citation xml:lang="en">Hagège A, Réant P, Habib G, Damy T, et al. Fabry disease in cardiology practice: literature review and expert point of view. Arch Cardiovasc Dis 2019;112:278–87. https://doi.org/10.1016/j.acvd.2019.01.002</mixed-citation></citation-alternatives></ref><ref id="cit189"><label>189</label><citation-alternatives><mixed-citation xml:lang="ru">Muhammad Umer and Dinesh K. Kalra. Cardiac MRI in Fabry disease. Front. Cardiovasc. Med. 9:1075639. https://doi.org/10.3389/fcvm.2022.1075639</mixed-citation><mixed-citation xml:lang="en">Muhammad Umer and Dinesh K. Kalra. Cardiac MRI in Fabry disease. Front. Cardiovasc. Med. 9:1075639. https://doi.org/10.3389/fcvm.2022.1075639</mixed-citation></citation-alternatives></ref><ref id="cit190"><label>190</label><citation-alternatives><mixed-citation xml:lang="ru">Gloria Caredda, Pier Paolo Bassareo, Maria Valeria Cherchi, et al. Anderson-fabry disease: role of traditional and new cardiac MRI techniques. Br J Radiol. 2021;94(1124):20210020. https://doi.org/10.1259/bjr.20210020</mixed-citation><mixed-citation xml:lang="en">Gloria Caredda, Pier Paolo Bassareo, Maria Valeria Cherchi, et al. Anderson-fabry disease: role of traditional and new cardiac MRI techniques. Br J Radiol. 2021;94(1124):20210020. https://doi.org/10.1259/bjr.20210020</mixed-citation></citation-alternatives></ref><ref id="cit191"><label>191</label><citation-alternatives><mixed-citation xml:lang="ru">Чесникова А.И., Ситникова М.Ю., Агеев Ф.Т., и соавт. Дилатационная кардиомиопатия. Клинические рекомендации 2025. Российский кардиологический журнал. 2026;31(5):6672. https://doi.org/10.15829/1560-4071-2026-6672</mixed-citation><mixed-citation xml:lang="en">Chesnikova A.I., Sitnikova M.Yu., Ageev F.T., et al. 2025 Clinical practice guidelines for Dilated cardiomyopathy. Russian Journal of Cardiology. 2026;31(5):6672. (In Russ.) https://doi.org/10.15829/1560-4071-2026-667</mixed-citation></citation-alternatives></ref><ref id="cit192"><label>192</label><citation-alternatives><mixed-citation xml:lang="ru">Голухова Е.З., Александрова С.А., Бердибеков Б.Ш. Прогностическая роль количественной оценки миокардиального фиброза по данным магнитно-резонансной томографии с отсроченным контрастированием при неишемических дилатационных кардиомиопатиях: систематический обзор и метаанализ. Российский кардиологический журнал. 2021;26(12):4776. https://doi.org/10.15829/1560-4071-2021-4776</mixed-citation><mixed-citation xml:lang="en">Golukhova E. Z., Aleksandrova S. A., Berdibekov B. Sh. Predictive role of quantification of myocardial fibrosis using delayed contrastenhanced magnetic resonance imaging in nonischemic dilated cardiomyopathies: a systematic review and meta-analysis. Russian Journal of Cardiology. 2021;26(12):4776. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4776</mixed-citation></citation-alternatives></ref><ref id="cit193"><label>193</label><citation-alternatives><mixed-citation xml:lang="ru">IIles LM, Ellims AH, Llewellyn H, et al. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. European heart journal cardiovascular Imaging. 2015;16:14-22. https://doi.org/10.1093/ehjci/jeu182</mixed-citation><mixed-citation xml:lang="en">IIles LM, Ellims AH, Llewellyn H, et al. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. European heart journal cardiovascular Imaging. 2015;16:14-22. https://doi.org/10.1093/ehjci/jeu182</mixed-citation></citation-alternatives></ref><ref id="cit194"><label>194</label><citation-alternatives><mixed-citation xml:lang="ru">Kalb B, Indik JH, Ott P, et al. MRI of patients with implanted cardiac devices. J Magn Reson Imaging. 2018;47(3):595-603. https://doi.org/10.1002/jmri.25824</mixed-citation><mixed-citation xml:lang="en">Kalb B, Indik JH, Ott P, et al. MRI of patients with implanted cardiac devices. J Magn Reson Imaging. 2018;47(3):595-603. https://doi.org/10.1002/jmri.25824</mixed-citation></citation-alternatives></ref><ref id="cit195"><label>195</label><citation-alternatives><mixed-citation xml:lang="ru">Игнатьева Е.С., Рыжкова Д.В., Митрофанова Л.Б., Моисеева О.М. Возможности магнитно-резонансной томографии в диагностике различных клинико-морфологических форм миокардита. Российский кардиологический журнал. 2017;(2):30-8. https://doi.org/10.15829/1560-4071-2017-2-30-38</mixed-citation><mixed-citation xml:lang="en">Ignatieva E.S., Ryzhkova D.V., Mitrofanova L.B., Moiseeva O.M. Magnetic resonance imaging of the heart in diagnostics of various types of myocarditis. Russian Journal of Cardiology. 2017;(2):30- 38. (In Russ.) https://doi.org/10.15829/1560-4071-2017-2-30-38</mixed-citation></citation-alternatives></ref><ref id="cit196"><label>196</label><citation-alternatives><mixed-citation xml:lang="ru">Chevalier C, Kremer K, Cavus E, et al. CMR feature tracking in patients with dilated cardiomyopathy: patterns of myocardial strain and focal fibrosis. Open Heart 2022;9:e002013. https://doi.org/10.1136/openhrt-2022-002013</mixed-citation><mixed-citation xml:lang="en">Chevalier C, Kremer K, Cavus E, et al. CMR feature tracking in patients with dilated cardiomyopathy: patterns of myocardial strain and focal fibrosis. Open Heart 2022;9:e002013. https://doi.org/10.1136/openhrt-2022-002013</mixed-citation></citation-alternatives></ref><ref id="cit197"><label>197</label><citation-alternatives><mixed-citation xml:lang="ru">Berdibekov BS, Alexandrova SA, Bulaeva NI, Golukhova EZ. Prognostic value of myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping in nonischemic dilated cardiomyopathy: a systematic review and meta-analysis. Clin Radiol. 2025 Jan;80:106726. https://doi.org/10.1016/j.crad.2024.10.007</mixed-citation><mixed-citation xml:lang="en">Berdibekov BS, Alexandrova SA, Bulaeva NI, Golukhova EZ. Prognostic value of myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping in nonischemic dilated cardiomyopathy: a systematic review and meta-analysis. Clin Radiol. 2025 Jan;80:106726. https://doi.org/10.1016/j.crad.2024.10.007</mixed-citation></citation-alternatives></ref><ref id="cit198"><label>198</label><citation-alternatives><mixed-citation xml:lang="ru">Min Jae Cha, Yoo Jin Hong, Chan Ho Park, et al. Utilities and Limitations of Cardiac Magnetic Resonance Imaging in Dilated Cardiomyopathy. Korean J Radiol 2023;24(12):1200-1220. https://doi.org/10.1038/s41572-019-0084-1</mixed-citation><mixed-citation xml:lang="en">Min Jae Cha, Yoo Jin Hong, Chan Ho Park, et al. Utilities and Limitations of Cardiac Magnetic Resonance Imaging in Dilated Cardiomyopathy. Korean J Radiol 2023;24(12):1200-1220. https://doi.org/10.1038/s41572-019-0084-1</mixed-citation></citation-alternatives></ref><ref id="cit199"><label>199</label><citation-alternatives><mixed-citation xml:lang="ru">Corrado D., A.Anastasakis, C.Basso, et al. Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report. Int J Cardiol. 2024;395:131447. https://doi.org/10.1016/j.ijcard.2023.131447</mixed-citation><mixed-citation xml:lang="en">Corrado D., A.Anastasakis, C.Basso, et al. Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report. Int J Cardiol. 2024;395:131447. https://doi.org/10.1016/j.ijcard.2023.131447</mixed-citation></citation-alternatives></ref><ref id="cit200"><label>200</label><citation-alternatives><mixed-citation xml:lang="ru">Thiene G. Research venture in arrhrythmogenic right ventricular cardiomyopathy: a paradigm of translational medicine. Eur Heart J. 2015;36(14):837-46. https://doi.org/10.1093/eurheartj/ehu493</mixed-citation><mixed-citation xml:lang="en">Thiene G. Research venture in arrhrythmogenic right ventricular cardiomyopathy: a paradigm of translational medicine. Eur Heart J. 2015;36(14):837-46. https://doi.org/10.1093/eurheartj/ehu493</mixed-citation></citation-alternatives></ref><ref id="cit201"><label>201</label><citation-alternatives><mixed-citation xml:lang="ru">Михайлов Е.Н., Гизатулина Т.П., Лебедев Д.С., и соавт. Желудочковые нарушения ритма сердца. Внезапная сердечная смерть. Клинические рекомендации 2025. Российский кардиологический журнал. 2025;30(11):6670. EDN: RLJANM. https://doi.org/10.15829/1560-4071-2025-6670</mixed-citation><mixed-citation xml:lang="en">Mikhailov E.N., Gizatulina T.P., Lebedev D.S., et al. Clinical practice guidelines for Ventricular arrhythmias of the heart and Sudden cardiac death. Russian Journal of Cardiology. 2025;30(11):6670. (In Russ.) https://doi.org/10.15829/1560-4071-2025-6670</mixed-citation></citation-alternatives></ref><ref id="cit202"><label>202</label><citation-alternatives><mixed-citation xml:lang="ru">Corrado D., P.J.van Tintelen, W.J.McKenna, et al. Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis. Eur Heart J. 2020;41(14):1414– 1429. https://doi.org/10.1093/eurheartj/ehz669</mixed-citation><mixed-citation xml:lang="en">Corrado D., P.J.van Tintelen, W.J.McKenna, et al. Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis. Eur Heart J. 2020;41(14):1414– 1429. https://doi.org/10.1093/eurheartj/ehz669</mixed-citation></citation-alternatives></ref><ref id="cit203"><label>203</label><citation-alternatives><mixed-citation xml:lang="ru">Marcus FI, McKenna WJ, Sherrill D, Basso C, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010 Apr 6;121(13):1533-41. https://doi.org/10.1161/circulationaha.108.840827</mixed-citation><mixed-citation xml:lang="en">Marcus FI, McKenna WJ, Sherrill D, Basso C, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010 Apr 6;121(13):1533-41. https://doi.org/10.1161/circulationaha.108.840827</mixed-citation></citation-alternatives></ref><ref id="cit204"><label>204</label><citation-alternatives><mixed-citation xml:lang="ru">Akdis D., Brunckhorst C., Duru F., et al. Update on arrhythmogenic cardiomyopathies Based on a lecture at the Cardiology Update Course 2017 in Davos. Cardiovascular Medicine. 2017;20(9):196– 202. https://doi.org/10.4414/cvm.2017.00512</mixed-citation><mixed-citation xml:lang="en">Akdis D., Brunckhorst C., Duru F., et al. Update on arrhythmogenic cardiomyopathies Based on a lecture at the Cardiology Update Course 2017 in Davos. Cardiovascular Medicine. 2017;20(9):196– 202. https://doi.org/10.4414/cvm.2017.00512</mixed-citation></citation-alternatives></ref><ref id="cit205"><label>205</label><citation-alternatives><mixed-citation xml:lang="ru">Александрова С.А., Глазкова Е.Ю., Голухова Е.З. Магнитно-резонансная томография сердца при аритмогенной кардиомиопатии: развитие критериев диагностики и новые возможности. Российский кардиологический журнал. 2024;29(11S):6118. https://doi.org/10.15829/1560-4071-2024-6118</mixed-citation><mixed-citation xml:lang="en">Aleksandrova S.A., Glazkova E.Yu., Golukhova E.Z. Cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy: evolving diagnostic criteria and new capabilities. Russian Journal of Cardiology. 2024;29(11S):6118. (In Russ.) https://doi.org/10.15829/1560-4071-2024-6118</mixed-citation></citation-alternatives></ref><ref id="cit206"><label>206</label><citation-alternatives><mixed-citation xml:lang="ru">F. Graziano, A. Zorzi, S. Ungaro, et al. The 2023 European Task Force Criteria for Diagnosis of Arrhythmogenic Cardiomyopathy: Historical Background and Review of Main Changes. Rev Cardiovasc Med. 2024;25(9):348. https://doi.org/10.31083/j.rcm2509348</mixed-citation><mixed-citation xml:lang="en">F. Graziano, A. Zorzi, S. Ungaro, et al. The 2023 European Task Force Criteria for Diagnosis of Arrhythmogenic Cardiomyopathy: Historical Background and Review of Main Changes. Rev Cardiovasc Med. 2024;25(9):348. https://doi.org/10.31083/j.rcm2509348</mixed-citation></citation-alternatives></ref><ref id="cit207"><label>207</label><citation-alternatives><mixed-citation xml:lang="ru">G.D.Aquaro, A.Barison, G.Todiere, et al. Usefulness of combined functional assessment by cardiac magnetic resonance and tissue characterization versus task force criteria for diagnosis of arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol. 2016;118:1730–1736. https://doi.org/10.1016/j.amjcard.2016.08.056</mixed-citation><mixed-citation xml:lang="en">G.D.Aquaro, A.Barison, G.Todiere, et al. Usefulness of combined functional assessment by cardiac magnetic resonance and tissue characterization versus task force criteria for diagnosis of arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol. 2016;118:1730–1736. https://doi.org/10.1016/j.amjcard.2016.08.056</mixed-citation></citation-alternatives></ref><ref id="cit208"><label>208</label><citation-alternatives><mixed-citation xml:lang="ru">Zhixiang Dong, Linlin Dai, Yanyan Song, et al. Right Ventricular Strain Derived from Cardiac MRI Feature Tracking for the Diagnosis and Prognosis of Arrhythmogenic Right Ventricular Cardiomyopathy. Radiology: Cardiothoracic Imaging 2024;6(3):e230292. https://doi.org/10.1148/ryct.230292</mixed-citation><mixed-citation xml:lang="en">Zhixiang Dong, Linlin Dai, Yanyan Song, et al. Right Ventricular Strain Derived from Cardiac MRI Feature Tracking for the Diagnosis and Prognosis of Arrhythmogenic Right Ventricular Cardiomyopathy. Radiology: Cardiothoracic Imaging 2024;6(3):e230292. https://doi.org/10.1148/ryct.230292</mixed-citation></citation-alternatives></ref><ref id="cit209"><label>209</label><citation-alternatives><mixed-citation xml:lang="ru">Nicola Galea, Gesualdo Polizzi, Marco Gatti, et al. Cardiovascular magnetic resonance (CMR) in restrictive cardiomyopathies. La radiologia medica. 2020;125:1072–1086. https://doi.org/10.1007/s11547-020-01287-8</mixed-citation><mixed-citation xml:lang="en">Nicola Galea, Gesualdo Polizzi, Marco Gatti, et al. Cardiovascular magnetic resonance (CMR) in restrictive cardiomyopathies. La radiologia medica. 2020;125:1072–1086. https://doi.org/10.1007/s11547-020-01287-8</mixed-citation></citation-alternatives></ref><ref id="cit210"><label>210</label><citation-alternatives><mixed-citation xml:lang="ru">Bishow Paudel, Jonathan Pan, Cristiane C. Singulane, et al. Cardiac Magnetic Resonance Guidance for the Pathogenetic Definition of Cardiomyopathies. Current Cardiology Reports. 2025;27:85. https://doi.org/10.1007/s11886-025-02233-8</mixed-citation><mixed-citation xml:lang="en">Bishow Paudel, Jonathan Pan, Cristiane C. Singulane, et al. Cardiac Magnetic Resonance Guidance for the Pathogenetic Definition of Cardiomyopathies. Current Cardiology Reports. 2025;27:85. https://doi.org/10.1007/s11886-025-02233-8</mixed-citation></citation-alternatives></ref><ref id="cit211"><label>211</label><citation-alternatives><mixed-citation xml:lang="ru">Xiaodan Li, Yan Chen, Jiayi Liu, et al. Cardiac magnetic resonance imaging of primary cardiac tumors. Quant Imaging Med Surg. 2020;10(1):294–313. https://doi.org/10.21037/qims.2019.11.13</mixed-citation><mixed-citation xml:lang="en">Xiaodan Li, Yan Chen, Jiayi Liu, et al. Cardiac magnetic resonance imaging of primary cardiac tumors. Quant Imaging Med Surg. 2020;10(1):294–313. https://doi.org/10.21037/qims.2019.11.13</mixed-citation></citation-alternatives></ref><ref id="cit212"><label>212</label><citation-alternatives><mixed-citation xml:lang="ru">Judith Bonnes, Monique Brink, Robin Nijveldt. How to evaluate cardiac masses by cardiovascular magnetic resonance parametric mapping? European Heart Journal Cardiovascular Imaging. 24(12):1605-1607. https://doi.org/10.1093/ehjci/jead221</mixed-citation><mixed-citation xml:lang="en">Judith Bonnes, Monique Brink, Robin Nijveldt. How to evaluate cardiac masses by cardiovascular magnetic resonance parametric mapping? European Heart Journal Cardiovascular Imaging. 24(12):1605-1607. https://doi.org/10.1093/ehjci/jead221</mixed-citation></citation-alternatives></ref><ref id="cit213"><label>213</label><citation-alternatives><mixed-citation xml:lang="ru">Sebastián Tonso, Santiago del Castillo, Fernando Garagoli et al. Assessment of cardiac masses by magnetic resonance imaging: prognostic value and agreement with histopathology. Current Problems in Cardiology. 2025;50(8):103084. https://doi.org/10.1016/j.cpcardiol.2025.103084</mixed-citation><mixed-citation xml:lang="en">Sebastián Tonso, Santiago del Castillo, Fernando Garagoli et al. Assessment of cardiac masses by magnetic resonance imaging: prognostic value and agreement with histopathology. Current Problems in Cardiology. 2025;50(8):103084. https://doi.org/10.1016/j.cpcardiol.2025.103084</mixed-citation></citation-alternatives></ref><ref id="cit214"><label>214</label><citation-alternatives><mixed-citation xml:lang="ru">Jelena Celutkien, Radek Pudil, Teresa López-Fernández, et al. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC). European Journal of Heart Failure. 2020;22:1504–1524. https://doi.org/10.1002/ejhf.1957</mixed-citation><mixed-citation xml:lang="en">Jelena Celutkien, Radek Pudil, Teresa López-Fernández, et al. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC). European Journal of Heart Failure. 2020;22:1504–1524. https://doi.org/10.1002/ejhf.1957</mixed-citation></citation-alternatives></ref><ref id="cit215"><label>215</label><citation-alternatives><mixed-citation xml:lang="ru">Farhad H, Staziaki P V, Addison D, et al. Characterization of the changes in cardiac structure and function in mice treated with anthracyclines using serial cardiac magnetic resonance imaging. Circ Cardiovasc Imaging. 2016;9:e003584. https://doi.org/10.1161/circimaging.115.003584</mixed-citation><mixed-citation xml:lang="en">Farhad H, Staziaki P V, Addison D, et al. Characterization of the changes in cardiac structure and function in mice treated with anthracyclines using serial cardiac magnetic resonance imaging. Circ Cardiovasc Imaging. 2016;9:e003584. https://doi.org/10.1161/circimaging.115.003584</mixed-citation></citation-alternatives></ref><ref id="cit216"><label>216</label><citation-alternatives><mixed-citation xml:lang="ru">Haslbauer JD, Lindner S, Valbuena-Lopez S, et al. CMR imaging biosignature of cardiac involvement due to cancerrelated treatment by T1 and T2 mapping. Int J Cardiol. 2019;275:179-86. https://doi.org/10.1016/j.ijcard.2018.10.023</mixed-citation><mixed-citation xml:lang="en">Haslbauer JD, Lindner S, Valbuena-Lopez S, et al. CMR imaging biosignature of cardiac involvement due to cancerrelated treatment by T1 and T2 mapping. Int J Cardiol. 2019;275:179-86. https://doi.org/10.1016/j.ijcard.2018.10.023</mixed-citation></citation-alternatives></ref><ref id="cit217"><label>217</label><citation-alternatives><mixed-citation xml:lang="ru">Greenwood JP, Maredia N, Younger JF, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): A prospective trial. Lancet 2012;379:453-60. https://doi.org/10.1016/s0140-6736(11)61335-4</mixed-citation><mixed-citation xml:lang="en">Greenwood JP, Maredia N, Younger JF, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): A prospective trial. Lancet 2012;379:453-60. https://doi.org/10.1016/s0140-6736(11)61335-4</mixed-citation></citation-alternatives></ref><ref id="cit218"><label>218</label><citation-alternatives><mixed-citation xml:lang="ru">Schwitter J, Wacker CM, Wilke N, et al. MR-IMPACT II: Magnetic resonance imaging for myocardial perfusion assessment in coronary artery disease trial: Perfusioncardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: A comparative. Eur Heart J 2013;34:775-81. https://doi.org/10.1093/eurheartj/ehs022</mixed-citation><mixed-citation xml:lang="en">Schwitter J, Wacker CM, Wilke N, et al. MR-IMPACT II: Magnetic resonance imaging for myocardial perfusion assessment in coronary artery disease trial: Perfusioncardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: A comparative. Eur Heart J 2013;34:775-81. https://doi.org/10.1093/eurheartj/ehs022</mixed-citation></citation-alternatives></ref><ref id="cit219"><label>219</label><citation-alternatives><mixed-citation xml:lang="ru">Levelt E, Rodgers CT, Clarke WT, et al. Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus. Eur Heart J 2016;37:3461-9. https://doi.org/10.1093/eurheartj/ehv442</mixed-citation><mixed-citation xml:lang="en">Levelt E, Rodgers CT, Clarke WT, et al. Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus. Eur Heart J 2016;37:3461-9. https://doi.org/10.1093/eurheartj/ehv442</mixed-citation></citation-alternatives></ref><ref id="cit220"><label>220</label><citation-alternatives><mixed-citation xml:lang="ru">Rider OJ, Francis JM, Ali MK, et al. Effects of catecholamine stress on diastolic function and myocardial energetics in obesity. Circulation 2012;125:1511-9. https://doi.org/10.1161/circulationaha.111.069518</mixed-citation><mixed-citation xml:lang="en">Rider OJ, Francis JM, Ali MK, et al. Effects of catecholamine stress on diastolic function and myocardial energetics in obesity. Circulation 2012;125:1511-9. https://doi.org/10.1161/circulationaha.111.069518</mixed-citation></citation-alternatives></ref><ref id="cit221"><label>221</label><citation-alternatives><mixed-citation xml:lang="ru">Dekker T, Kirkels JH, Ruigrok TJ, et al. Chronic cardiotoxicity of adriamycin studied in a rat model by 31P NMR. NMR Biomed 1991;4:16-24. https://doi.org/10.1002/nbm.1940040104</mixed-citation><mixed-citation xml:lang="en">Dekker T, Kirkels JH, Ruigrok TJ, et al. Chronic cardiotoxicity of adriamycin studied in a rat model by 31P NMR. NMR Biomed 1991;4:16-24. https://doi.org/10.1002/nbm.1940040104</mixed-citation></citation-alternatives></ref><ref id="cit222"><label>222</label><citation-alternatives><mixed-citation xml:lang="ru">Bittner V, Reeves RC, Digerness SB, et al. 31P NMR spectroscopy in chronic adriamycin cardiotoxicity. Magn Reson Med 1991;17:69- 81. https://doi.org/10.1002/mrm.1910170112</mixed-citation><mixed-citation xml:lang="en">Bittner V, Reeves RC, Digerness SB, et al. 31P NMR spectroscopy in chronic adriamycin cardiotoxicity. Magn Reson Med 1991;17:69- 81. https://doi.org/10.1002/mrm.1910170112</mixed-citation></citation-alternatives></ref><ref id="cit223"><label>223</label><citation-alternatives><mixed-citation xml:lang="ru">Maslov MY, Chacko VP, Hirsch GA, et al. Reduced in vivo high-energy phosphates precede adriamycin-induced cardiac dysfunction. Am J Physiol Heart Circ Physiol 2010;299:H332-7. https://doi.org/10.1152/ajpheart.00727.2009</mixed-citation><mixed-citation xml:lang="en">Maslov MY, Chacko VP, Hirsch GA, et al. Reduced in vivo high-energy phosphates precede adriamycin-induced cardiac dysfunction. Am J Physiol Heart Circ Physiol 2010;299:H332-7. https://doi.org/10.1152/ajpheart.00727.2009</mixed-citation></citation-alternatives></ref><ref id="cit224"><label>224</label><citation-alternatives><mixed-citation xml:lang="ru">Timm KN, Perera C, Ball V, et al. Mitochondrial dysfunction in a rat model of doxorubicin-induced heart failure assessed by hyperpolarized 13C MRS. In: Proceedings of the International Society for Magnetic Resonance in Medicine. 2019;27:078.</mixed-citation><mixed-citation xml:lang="en">Timm KN, Perera C, Ball V, et al. Mitochondrial dysfunction in a rat model of doxorubicin-induced heart failure assessed by hyperpolarized 13C MRS. In: Proceedings of the International Society for Magnetic Resonance in Medicine. 2019;27:078.</mixed-citation></citation-alternatives></ref><ref id="cit225"><label>225</label><citation-alternatives><mixed-citation xml:lang="ru">Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374–379. https://doi.org/10.1016/S0140-6736(03)12389-6</mixed-citation><mixed-citation xml:lang="en">Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374–379. https://doi.org/10.1016/S0140-6736(03)12389-6</mixed-citation></citation-alternatives></ref><ref id="cit226"><label>226</label><citation-alternatives><mixed-citation xml:lang="ru">Christoph J. Jensen, Markus Jochims, Peter Hunold, et al. Right Ventricular Involvement inAcute Left Ventricular MyocardialInfarction: Prognostic Implicationsof MRI Findings. AJR 2010;194:592–598. https://doi.org/10.2214/AJR.09.2829</mixed-citation><mixed-citation xml:lang="en">Christoph J. Jensen, Markus Jochims, Peter Hunold, et al. Right Ventricular Involvement inAcute Left Ventricular MyocardialInfarction: Prognostic Implicationsof MRI Findings. AJR 2010;194:592–598. https://doi.org/10.2214/AJR.09.2829</mixed-citation></citation-alternatives></ref><ref id="cit227"><label>227</label><citation-alternatives><mixed-citation xml:lang="ru">Manandhar S, Chhetri S, Tannenbaum J, Alvarez M, Pokharel Y. Isolated right ventricular infarction - Unmasking the masquerader. J Cardiol Cases. 2025 May 1;32(1):36-38. https://doi.org/10.1016/j.jccase.2025.04.005</mixed-citation><mixed-citation xml:lang="en">Manandhar S, Chhetri S, Tannenbaum J, Alvarez M, Pokharel Y. Isolated right ventricular infarction - Unmasking the masquerader. J Cardiol Cases. 2025 May 1;32(1):36-38. https://doi.org/10.1016/j.jccase.2025.04.005</mixed-citation></citation-alternatives></ref><ref id="cit228"><label>228</label><citation-alternatives><mixed-citation xml:lang="ru">Mayooran Shanmuganathan, Chrysovalantou Nikolaidou, Matthew K. Burrage,et al. Cardiovascular Magnetic Resonance Before Invasive Coronary Angiography in Suspected Non–ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol Img 2024;17:1044-1058 https://doi.org/10.1016/j.jcmg.2024.05.007</mixed-citation><mixed-citation xml:lang="en">Mayooran Shanmuganathan, Chrysovalantou Nikolaidou, Matthew K. Burrage,et al. Cardiovascular Magnetic Resonance Before Invasive Coronary Angiography in Suspected Non–ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol Img 2024;17:1044-1058 https://doi.org/10.1016/j.jcmg.2024.05.007</mixed-citation></citation-alternatives></ref><ref id="cit229"><label>229</label><citation-alternatives><mixed-citation xml:lang="ru">Бердибеков Б.Ш., Александрова С.А., Булаева Н.И., Голухова Е.З. Роль магнитно-резонансной томографии при инфаркте миокарда без обструкции коронарных артерий. Креативная кардиология. 2025;19(1):7-16. https://doi.org/10.24022/1997-3187-2025-19-1-7-16</mixed-citation><mixed-citation xml:lang="en">Berdibekov B.Sh., Alexandrova S.A., Bulaeva N.I., Golukhova E.Z. The role of magnetic resonance imaging in myocardial infarction with non-obstructive coronary arteries. Creative Cardiology. 2025;19(1):7-16. (In Russ.) https://doi.org/10.24022/1997-3187-2025-19-1-7-16</mixed-citation></citation-alternatives></ref><ref id="cit230"><label>230</label><citation-alternatives><mixed-citation xml:lang="ru">Тереничева М.А., Стукалова О.В., Шахнович Р.М., Терновой С.К. Роль магнитно-резонансной томографии сердца в определении прогноза больных с острым инфарктом миокарда с подъемом сегмента ST. Часть 1. Показания и противопоказания к исследованию. Основные методики. Терапевтический архив. 2021;93(4):497–501. https://doi.org/10.26442/00403660.2021.04.200687</mixed-citation><mixed-citation xml:lang="en">Terenicheva MA, Stukalova OV, Shakhnovich RM, Ternovoy SK. The role of cardiac magnetic resonance imaging (cardiovascular magnetic resonance) in defining the prognosis of patients with acute ST-segment elevation myocardial infarction. Part 1. Indications and contraindications to cardiovascular magnetic resonance. Terapevticheskii Arkhiv (Ter. Arkh.). 2021;93(4):497-501. (In Russ.) https://doi.org/10.26442/00403660.2021.04.200687</mixed-citation></citation-alternatives></ref><ref id="cit231"><label>231</label><citation-alternatives><mixed-citation xml:lang="ru">Чернявский А.М., Московских М.А., Протопопов А.В. Хрущев С.Е., Сирота Д.А. Роль магнитно-резонансной томографии в диагностике постинфарктных аневризм левого желудочка: одноцентровое проспективное наблюдательное исследование. Патология кровообращения и кардиохирургия. 2026;30(1):55- 66. https://doi.org/10.21688/1681-3472-2026-1-55-66</mixed-citation><mixed-citation xml:lang="en">Chernyavskiy A.M., Moskovskih M.A., Protopopov A.V., Khrushchev S.E.K., Sirota D.A. The role of magnetic resonance imaging in the diagnosis of post-infarction left ventricular aneurysms: a single-center prospective observational study. Patologiya Krovoobrashcheniya I Kardiokhirurgiya. 2026;30(1):55– 66. (In Russ.) https://doi.org/10.21688/1681-3472-2026-1-55-66</mixed-citation></citation-alternatives></ref><ref id="cit232"><label>232</label><citation-alternatives><mixed-citation xml:lang="ru">Baicha A, Aboubakr K, Mouine N, et al. (June 22, 2026) Giant Left Ventricular Intracavitary Mass: Diagnostic Challenges in Distinguishing Thrombus From Tumor. Cureus 18(6): e111308. https://doi.org/10.7759/cureus.111308</mixed-citation><mixed-citation xml:lang="en">Baicha A, Aboubakr K, Mouine N, et al. (June 22, 2026) Giant Left Ventricular Intracavitary Mass: Diagnostic Challenges in Distinguishing Thrombus From Tumor. Cureus 18(6): e111308. https://doi.org/10.7759/cureus.111308</mixed-citation></citation-alternatives></ref><ref id="cit233"><label>233</label><citation-alternatives><mixed-citation xml:lang="ru">Krishnan U, McCann GP, Hickey M, et al. Role of contrast-enhanced magnetic resonance imaging in detecting early adverse remodeling and subacute ventricular wall rupture complicating myocardial infarction. Heart and Vessels, 27 Nov 2008, 23(6):430-432. https://doi.org/10.1007/s00380-008-1063-8</mixed-citation><mixed-citation xml:lang="en">Krishnan U, McCann GP, Hickey M, et al. Role of contrast-enhanced magnetic resonance imaging in detecting early adverse remodeling and subacute ventricular wall rupture complicating myocardial infarction. Heart and Vessels, 27 Nov 2008, 23(6):430-432. https://doi.org/10.1007/s00380-008-1063-8</mixed-citation></citation-alternatives></ref><ref id="cit234"><label>234</label><citation-alternatives><mixed-citation xml:lang="ru">Manuel De Lazzari, Alberto Cipriani, Annagrazia Cecere, et al. Cardiac rupture in acute myocardial infarction: a cardiac magnetic resonance study. European Heart Journal – Cardiovascular Imaging (2023) 24, 1491–1500. https://doi.org/10.1093/ehjci/jead088</mixed-citation><mixed-citation xml:lang="en">Manuel De Lazzari, Alberto Cipriani, Annagrazia Cecere, et al. Cardiac rupture in acute myocardial infarction: a cardiac magnetic resonance study. European Heart Journal – Cardiovascular Imaging (2023) 24, 1491–1500. https://doi.org/10.1093/ehjci/jead088</mixed-citation></citation-alternatives></ref><ref id="cit235"><label>235</label><citation-alternatives><mixed-citation xml:lang="ru">Тереничева М.А., Шахнович Р.М., Стукалова О.В., и соавт. Значение микрососудистой обструкции по данным контрастной магнитно-резонансной томографии сердца в оценке прогноза больных с острым инфарктом миокарда с подъемом сегмента ST. Российский кардиологический журнал. 2024;29(3):84-90. https://doi.org/10.15829/1560-4071-2024-5603</mixed-citation><mixed-citation xml:lang="en">Terenicheva M.A., Shakhnovich R.M., Stukalova O.V., Pevzner D.V., Yavelov I.S., Shalaginova Yu.O., Ternovoy S.K. The value of microvascular obstruction according to contrast-enhanced cardiac magnetic resonance imaging in assessing the prognosis of patients with acute ST-segment elevation myocardial infarction. Russian Journal of Cardiology. 2024;29(3):84-90. (In Russ.) https://doi.org/10.15829/1560-4071-2024-5603</mixed-citation></citation-alternatives></ref><ref id="cit236"><label>236</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Q, Fotaki A, Ghadimi S, et al. Improving the efficiency and accuracy of cardiovascular magnetic resonance with artificial intelligence—review of evidence and proposition of a roadmap to clinical translation. J Cardiovasc Magn Reson. 2024;26:101051. https://doi.org/10.1016/j.jocmr.2024.101051</mixed-citation><mixed-citation xml:lang="en">Zhang Q, Fotaki A, Ghadimi S, et al. Improving the efficiency and accuracy of cardiovascular magnetic resonance with artificial intelligence—review of evidence and proposition of a roadmap to clinical translation. J Cardiovasc Magn Reson. 2024;26:101051. https://doi.org/10.1016/j.jocmr.2024.101051</mixed-citation></citation-alternatives></ref><ref id="cit237"><label>237</label><citation-alternatives><mixed-citation xml:lang="ru">Leiner T, Rueckert D, Suinesiaputra A, et al. Machine learning in cardiovascular magnetic resonance: basic concepts and applications. Journal of Cardiovascular Magnetic Resonance. 2019;21:61. https://doi.org/10.1186/s12968-019-0575-y</mixed-citation><mixed-citation xml:lang="en">Leiner T, Rueckert D, Suinesiaputra A, et al. Machine learning in cardiovascular magnetic resonance: basic concepts and applications. Journal of Cardiovascular Magnetic Resonance. 2019;21:61. https://doi.org/10.1186/s12968-019-0575-y</mixed-citation></citation-alternatives></ref><ref id="cit238"><label>238</label><citation-alternatives><mixed-citation xml:lang="ru">Contijoch F, Rasche V, Seiberlich N, Peters DC. The future of CMR: All-in-one vs. real-time CMR (Part 2). J Cardiovasc Magn Reson. 2024;26:100998. https://doi.org/10.1016/j.jocmr.2024.100998</mixed-citation><mixed-citation xml:lang="en">Contijoch F, Rasche V, Seiberlich N, Peters DC. The future of CMR: All-in-one vs. real-time CMR (Part 2). J Cardiovasc Magn Reson. 2024;26:100998. https://doi.org/10.1016/j.jocmr.2024.100998</mixed-citation></citation-alternatives></ref><ref id="cit239"><label>239</label><citation-alternatives><mixed-citation xml:lang="ru">Dall’Armellina E, Ennis DB, Leon Axel L, et al. Cardiac diffusion- 241of the Society for Cardiovascular Magnetic Resonance. J Cardiovasc Magn Reson. 2025;27:101109. https://doi.org/10.1016/j.jocmr.2024.101109</mixed-citation><mixed-citation xml:lang="en">Dall’Armellina E, Ennis DB, Leon Axel L, et al. Cardiac diffusion- 241of the Society for Cardiovascular Magnetic Resonance. J Cardiovasc Magn Reson. 2025;27:101109. https://doi.org/10.1016/j.jocmr.2024.101109</mixed-citation></citation-alternatives></ref><ref id="cit240"><label>240</label><citation-alternatives><mixed-citation xml:lang="ru">Velasco C., Fletcher T.J., Botnar R.M., Prieto C. Artificial intelligence in cardiac magnetic resonance fingerprinting. Front Cardiovasc Med. 2022;9 PMID: 36204566; PMCID: PMC9530662. https://doi.org/10.3389/fcvm.2022.1009131</mixed-citation><mixed-citation xml:lang="en">Velasco C., Fletcher T.J., Botnar R.M., Prieto C. Artificial intelligence in cardiac magnetic resonance fingerprinting. Front Cardiovasc Med. 2022;9 PMID: 36204566; PMCID: PMC9530662. https://doi.org/10.3389/fcvm.2022.1009131</mixed-citation></citation-alternatives></ref><ref id="cit241"><label>241</label><citation-alternatives><mixed-citation xml:lang="ru">Chiribiri A, Arai AE, DiBella E, et al. Society for Cardiovascular Magnetic Resonance expert consensus statement on quantitative myocardial perfusion cardiovascular magnetic resonance imaging. J Cardiovasc Magn Reson. 2025;27:101940. https://doi.org/10.1016/j.jocmr.2025.101940</mixed-citation><mixed-citation xml:lang="en">Chiribiri A, Arai AE, DiBella E, et al. Society for Cardiovascular Magnetic Resonance expert consensus statement on quantitative myocardial perfusion cardiovascular magnetic resonance imaging. J Cardiovasc Magn Reson. 2025;27:101940. https://doi.org/10.1016/j.jocmr.2025.101940</mixed-citation></citation-alternatives></ref><ref id="cit242"><label>242</label><citation-alternatives><mixed-citation xml:lang="ru">Mao X., Lee H.-L., Hu Z., et al. Simultaneous Multi-Slice Cardiac MR Multitasking for Motion-Resolved, Non-ECG, Free-Breathing T1–T2 Mapping. Front Cardiovasc Med. 2022;9:1–13. https://doi.org/10.3389/fcvm.2022.833257</mixed-citation><mixed-citation xml:lang="en">Mao X., Lee H.-L., Hu Z., et al. Simultaneous Multi-Slice Cardiac MR Multitasking for Motion-Resolved, Non-ECG, Free-Breathing T1–T2 Mapping. Front Cardiovasc Med. 2022;9:1–13. https://doi.org/10.3389/fcvm.2022.833257</mixed-citation></citation-alternatives></ref><ref id="cit243"><label>243</label><citation-alternatives><mixed-citation xml:lang="ru">Kawel-Boehm N., Hetzel SJ., Ambale-Venkatesh B., Captur G., et al. Society for Cardiovascular Magnetic Resonance reference values (“normal values”) in cardiovascular magnetic resonance: 2025 update. J Cardiovasc Magn Reson. 2025 Feb 4;27(1):101853. https://doi.org/10.1016/j.jocmr.2025.101853</mixed-citation><mixed-citation xml:lang="en">Kawel-Boehm N., Hetzel SJ., Ambale-Venkatesh B., Captur G., et al. Society for Cardiovascular Magnetic Resonance reference values (“normal values”) in cardiovascular magnetic resonance: 2025 update. J Cardiovasc Magn Reson. 2025 Feb 4;27(1):101853. https://doi.org/10.1016/j.jocmr.2025.101853</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
